paper-ii social medicine & community health · 2019. 9. 29. · paper-ii 2 d-81-14 social...

1. Write your roll number in the space provided on the top ofthis page.

2. This paper consists of fifty multiple-choice type of questions.3. At the commencement of examination, the question booklet

will be given to you. In the first 5 minutes, you are requestedto open the booklet and compulsorily examine it as below :(i) To have access to the Question Booklet, tear off the

paper seal on the edge of this cover page. Do not accepta booklet without sticker-seal and do not accept an openbooklet.

(ii) Tally the number of pages and number of questionsin the booklet with the information printed on thecover page. Faulty booklets due to pages/questionsmissing or duplicate or not in serial order or anyother discrepancy should be got replaced immediatelyby a correct booklet from the invigilator within theperiod of 5 minutes. Afterwards, neither the QuestionBooklet will be replaced nor any extra time will begiven.

(iii) After this verification is over, the OMR Sheet Numbershould be entered on this Test Booklet.

4. Each item has four alternative responses marked (A), (B), (C)and (D). You have to darken the circle as indicated below on

the correct response against each item.

Example :

where (C) is the correct response.5. Your responses to the items are to be indicated in the OMR

Sheet given inside the Paper I Booklet only. If you markat any place other than in the circle in the OMR Sheet, it willnot be evaluated.

6. Read instructions given inside carefully.7. Rough Work is to be done in the end of this booklet.8. If you write your Name, Roll Number, Phone Number or put

any mark on any part of the OMR Sheet, except for the spaceallotted for the relevant entries, which may disclose youridentity, or use abusive language or employ any other unfairmeans such as change of response by scratching or usingwhite fluid, you will render yourself liable to disqualification.

9. You have to return the test question booklet and OriginalOMR Sheet to the invigilators at the end of the examinationcompulsorily and must not carry it with you outside theExamination Hall. You are, however, allowed to carry originalquestion booklet and duplicate copy of OMR Sheet onconclusion of examination.

10. Use only Blue/Black Ball point pen.11. Use of any calculator or log table etc., is prohibited.12. There is no negative marks for incorrect answers.13. In case of any discrepancy in the English and Hindi versions,

English version will be taken as final.

Number of Pages in this Booklet : 24 Number of Questions in this Booklet : 50

Instructions for the Candidates ¯Ö¸üßõÖÖÙ£ÖµÖÖë Ûêú ×»Ö‹ ×®Ö¤ìü¿Ö1. ‡ÃÖ ¯ÖéÂšü Ûêú ‰ú¯Ö¸ü ×®ÖµÖŸÖ Ã£ÖÖ®Ö ¯Ö¸ü †¯Ö®ÖÖ ¸üÖê»Ö ®Ö´²Ö¸ü ×»Ö×ÜÖ‹ …2. ‡ÃÖ ¯ÖÏ¿®Ö-¯Ö¡Ö ´Öë ¯Ö“ÖÖÃÖ ²ÖÆãü×¾ÖÛú»¯ÖßµÖ ¯ÖÏ¿®Ö Æïü …3. ¯Ö¸üßõÖÖ ¯ÖÏÖ¸ü´³Ö ÆüÖê®Öê ¯Ö¸ü, ¯ÖÏ¿®Ö-¯Öã×ÃŸÖÛúÖ †Ö¯ÖÛúÖê ¤êü ¤üß •ÖÖµÖêÝÖß … ¯ÖÆü»Öê

¯ÖÖÑ“Ö ×´Ö®Ö™ü †Ö¯ÖÛúÖê ¯ÖÏ¿®Ö-¯Öã×ÃŸÖÛúÖ ÜÖÖê»Ö®Öê ŸÖ£ÖÖ ˆÃÖÛúß ×®Ö´®Ö×»Ö×ÜÖŸÖ•ÖÖÑ“Ö Ûêú ×»Ö‹ ×¤üµÖê •ÖÖµÖëÝÖê, ×•ÖÃÖÛúß •ÖÖÑ“Ö †Ö¯ÖÛúÖê †¾Ö¿µÖ Ûú¸ü®Öß Æîü :(i) ¯ÖÏ¿®Ö-¯Öã×ÃŸÖÛúÖ ÜÖÖê»Ö®Öê Ûêú ×»Ö‹ ˆÃÖÛêú Ûú¾Ö¸ü ¯Öê•Ö ¯Ö¸ü »ÖÝÖß ÛúÖÝÖ•Ö

Ûúß ÃÖß»Ö ÛúÖê ±úÖ›Ìü »Öë … ÜÖã»Öß Æãü‡Ô µÖÖ ×²Ö®ÖÖ Ã™üßÛú¸ü-ÃÖß»Ö Ûúß¯Öã×ÃŸÖÛúÖ Ã¾ÖßÛúÖ¸ü ®Ö Ûú¸ëü …

(ii) Ûú¾Ö¸ü ¯ÖéÂšü ¯Ö¸ü ”û¯Öê ×®Ö¤ìü¿ÖÖ®ÖãÃÖÖ¸ü ¯ÖÏ¿®Ö-¯Öã×ÃŸÖÛúÖ Ûêú ¯ÖéÂšü ŸÖ£ÖÖ¯ÖÏ¿®ÖÖë Ûúß ÃÖÓÜµÖÖ ÛúÖê †“”ûß ŸÖ¸üÆü “ÖîÛú Ûú¸ü »Öë ×Ûú µÖê ¯Öæ¸êüÆïü … ¤üÖêÂÖ¯ÖæÞÖÔ ¯Öã×ÃŸÖÛúÖ ×•Ö®Ö´Öë ¯ÖéÂšü/¯ÖÏ¿®Ö Ûú´Ö ÆüÖë µÖÖ ¤ãü²ÖÖ üÖ †ÖÝÖµÖê ÆüÖë µÖÖ ÃÖß×¸üµÖ»Ö ´Öë ®Ö ÆüÖë †£ÖÖÔŸÖË ×ÛúÃÖß ³Öß ¯ÖÏÛúÖ¸ü Ûúß¡Öã×™ü¯ÖæÞÖÔ ¯Öã×ÃŸÖÛúÖ Ã¾ÖßÛúÖ¸ü ®Ö Ûú¸ëü ŸÖ£ÖÖ ˆÃÖß ÃÖ´ÖµÖ ˆÃÖê»ÖÖî™üÖÛú¸ü ˆÃÖÛêú Ã£ÖÖ®Ö ¯Ö¸ü ¤æüÃÖ¸üß ÃÖÆüß ¯ÖÏ¿®Ö-¯Öã×ÃŸÖÛúÖ »Öê »Öë …‡ÃÖÛêú ×»Ö‹ †Ö¯ÖÛúÖê ¯ÖÖÑ“Ö ×´Ö®Ö™ü ×¤üµÖê •ÖÖµÖëÝÖê … ˆÃÖÛêú ²ÖÖ¤ü ®ÖŸÖÖê †Ö¯ÖÛúß ¯ÖÏ¿®Ö-¯Öã×ÃŸÖÛúÖ ¾ÖÖ¯ÖÃÖ »Öß •ÖÖµÖêÝÖß †Öî ü ®Ö Æüß †Ö¯ÖÛúÖê†×ŸÖ×¸üŒŸÖ ÃÖ´ÖµÖ ×¤üµÖÖ •ÖÖµÖêÝÖÖ …

(iii) ‡ÃÖ •ÖÖÑ“Ö Ûêú ²ÖÖ¤ü OMR ¯Ö¡ÖÛú Ûúß ÛÎú´Ö ÃÖÓÜµÖÖ ‡ÃÖ ¯ÖÏ¿®Ö-¯Öã×ÃŸÖÛúÖ¯Ö¸ü †Ó×ÛúŸÖ Ûú¸ü ¤ëü …

4. ¯ÖÏŸµÖêÛú ¯ÖÏ¿®Ö Ûêú ×»Ö‹ “ÖÖ¸ü ˆ¢Ö¸ü ×¾ÖÛú»¯Ö (A), (B), (C) ŸÖ£ÖÖ (D) ×¤üµÖêÝÖµÖê Æïü … †Ö¯ÖÛúÖê ÃÖÆüß ˆ¢Ö¸ü Ûêú ¾Öé¢Ö ÛúÖê ¯Öê®Ö ÃÖê ³Ö¸üÛú¸ü ÛúÖ»ÖÖ Ûú¸ü®ÖÖ Æîü•ÖîÃÖÖ ×Ûú ®Öß“Öê ×¤üÜÖÖµÖÖ ÝÖµÖÖ Æîü …ˆ¤üÖÆü¸üÞÖ :•Ö²Ö×Ûúú(C) ÃÖÆüß ˆ¢Ö¸ü Æîü …

5. ¯ÖÏ¿®ÖÖë Ûêú ¢Ö¸ü Ûêú¾Ö»Ö ÖÏ¿®Ö Ö¡Ö I Ûêú †®¤ü¸ü ×¤üµÖê ÝÖµÖê OMR Ö¡ÖÛú Ö¸ü Æüß†Ó×ÛúŸÖ Ûú¸ü®Öê Æïü … µÖ×¤ü †Ö¯Ö OMR ¯Ö¡ÖÛú ¯Ö¸ü ×¤üµÖê ÝÖµÖê ¾Öé¢Ö Ûêú †»ÖÖ¾ÖÖ×ÛúÃÖß †®µÖ Ã£ÖÖ®Ö ¯Ö¸ü ˆ¢Ö¸ü ×“ÖÅ®ÖÖÓ×ÛúŸÖ Ûú¸üŸÖê Æïü, ŸÖÖê ˆÃÖÛúÖ ´Öæ»µÖÖÓÛú®Ö®ÖÆüà ÆüÖêÝÖÖ …

6. †®¤ü¸ü ×¤üµÖê ÝÖµÖê ×®Ö¤ìü¿ÖÖë ÛúÖê ¬µÖÖ®Ö¯Öæ¾ÖÔÛú ¯ÖœÌëü …7. Ûú““ÖÖ ÛúÖ´Ö (Rough Work) ‡ÃÖ ¯Öã×ÃŸÖÛúÖ Ûêú †×®ŸÖ´Ö ¯ÖéÂšü ¯Ö¸ü Ûú¸ëü …8. µÖ×¤ü †Ö¯Ö OMR ¯Ö¡ÖÛú ¯Ö¸ü ×®ÖµÖŸÖ Ã£ÖÖ®Ö Ûêú †»ÖÖ¾ÖÖ †¯Ö®ÖÖ ®ÖÖ´Ö, ¸üÖê»Ö

®Ö´²Ö¸ü, ±úÖê®Ö ®Ö´²Ö¸ü µÖÖ ÛúÖê‡Ô ³Öß ‹êÃÖÖ ×“ÖÅ®Ö ×•ÖÃÖÃÖê †Ö¯ÖÛúß ¯ÖÆü“ÖÖ®Ö ÆüÖêÃÖÛêú, †Ó×ÛúŸÖ Ûú¸üŸÖê Æïü †£Ö¾ÖÖ †³Ö¦ü ³ÖÖÂÖÖ ÛúÖ ¯ÖÏµÖÖêÝÖ Ûú¸üŸÖê Æïü, µÖÖ ÛúÖê‡Ô†®µÖ †®Öã×“ÖŸÖ ÃÖÖ¬Ö®Ö ÛúÖ ¯ÖÏµÖÖêÝÖ Ûú¸üŸÖê Æïü, •ÖîÃÖê ×Ûú †Ó×ÛúŸÖ ×ÛúµÖê ÝÖµÖêˆ¢Ö¸ü ÛúÖê ×´Ö™üÖ®ÖÖ µÖÖ ÃÖ±êú¤ü ÃµÖÖÆüß ÃÖê ²Ö¤ü»Ö®ÖÖ ŸÖÖê ¯Ö¸üßõÖÖ Ûêú ×»ÖµÖê†µÖÖêÝµÖ ‘ÖÖê×ÂÖŸÖ ×ÛúµÖê •ÖÖ ÃÖÛúŸÖê Æïü …

9. †Ö¯ÖÛúÖê ¯Ö¸üßõÖÖ ÃÖ´ÖÖ¯ŸÖ ÆüÖê®Öê ¯Ö¸ü ¯ÖÏ¿®Ö-¯Öã×ÃŸÖÛúÖ ‹¾ÖÓ ´Öæ»Ö OMR ¯Ö¡ÖÛú×®Ö¸üßõÖÛú ´ÖÆüÖê¤üµÖ ÛúÖê »ÖÖî™üÖ®ÖÖ †Ö¾Ö¿µÖÛú Æîü †Öî¸ü ¯Ö¸üßõÖÖ ÃÖ´ÖÖ×¯ŸÖ Ûêú ²ÖÖ¤üˆÃÖê †¯Ö®Öê ÃÖÖ£Ö ¯Ö¸üßõÖÖ ³Ö¾Ö®Ö ÃÖê ²ÖÖÆü¸ü ®Ö »ÖêÛú¸ü •ÖÖµÖë … ÆüÖ»ÖÖÓ×Ûú †Ö¯Ö¯Ö¸üßõÖÖ ÃÖ´ÖÖ×¯ŸÖ ¯Ö¸ü ´Öæ»Ö ¯ÖÏ¿®Ö-¯Öã×ÃŸÖÛúÖ ŸÖ£ÖÖ OMR ¯Ö¡ÖÛú Ûúß ›ãü¯»ÖßÛêú™ü¯ÖÏ×ŸÖ †¯Ö®Öê ÃÖÖ£Ö »Öê •ÖÖ ÃÖÛúŸÖê Æïü …

10. Ûêú¾Ö»Ö ®Öß»Öê/ÛúÖ»Öê ²ÖÖ»Ö ¯¾ÖÖ‡Õ™ü ¯Öê®Ö ÛúÖ Æüß ‡ÃŸÖê ÖÖ»Ö Ûú ëü …11. ×ÛúÃÖß ³Öß ¯ÖÏÛúÖ¸ü ÛúÖ ÃÖÓÝÖÞÖÛú (Ûîú»ÖÛãú»Öê™ü¸ü) µÖÖ »ÖÖÝÖ ™êü²Ö»Ö †Ö×¤ü ÛúÖ

¯ÖÏµÖÖêÝÖ ¾ÖÙ•ÖŸÖ Æîü …12. ÝÖ»ÖŸÖ ˆ¢Ö¸üÖë Ûêú ×»Ö‹ ÛúÖê‡Ô ®ÖÛúÖ¸üÖŸ´ÖÛú †ÓÛú ®ÖÆüà Æïü …13. µÖ×¤ü †ÓÝÖÏê•Öß µÖÖ ØÆü¤üß ×¾Ö¾Ö¸üÞÖ ´Öë ÛúÖê‡Ô ×¾ÖÃÖÓÝÖ×ŸÖ ÆüÖê, ŸÖÖê †ÓÝÖÏê•Öß ×¾Ö¾Ö¸üÞÖ

†Ó×ŸÖ´Ö ´ÖÖ®ÖÖ •ÖÖ‹ÝÖÖ …

[Maximum Marks : 100Time : 1 1/4 hours]

PAPER-II

(To be filled by the Candidate)

Signature and Name of Invigilator

OMR Sheet No. : ...............................................

Roll No.

(In words)

1. (Signature) __________________________

(Name) ____________________________

2. (Signature) __________________________

(Name) ____________________________Roll No.________________________________

8 1

(In figures as per admission card)

D 1 4

D-81-14 1 P.T.O.

SOCIAL MEDICINE & COMMUNITY HEALTH

Paper-II 2 D-81-14

SOCIAL MEDICINE & COMMUNITY HEALTH

Paper – II

Note : This paper contains fifty (50) objective type questions of two (2) marks each. All

questions are compulsory.

1. Which of the following nutritional programme comes under the purview of M.O.H.F.W ?

(A) Prophylaxis against nutritional anaemia.

(B) Mid-day Meal Programme

(C) ICDS Programme

(D) Special Nutrition Programme

2. The Central Council of Health was constituted with Union Health Minister as Chairman

and the Health Ministers of the States as members in the year

(A) 1950 (B) 1952

(C) 1954 (D) 1957

3. Which of the following is not an element of Primary Health Care ?

(A) Immunization

(B) Appropriate treatment of common diseases

(C) Appropriate technology

(D) Provision of essential drugs

4. ‘The Conditions of the Working Class in England’ was written by

(A) A Gidders (B) K. Marx

(C) F. Engels (D) Adam Smith

5. Which year was ‘caste’ test enumerated in the Census of India ?

(A) 1941 (B) 1931

(C) 1911 (D) 1921

6. Approach to bio-medical model is

(A) Collectivism (B) Positivism

(C) Participatory (D) None of the above

7. Reporting of female-morbidity will be enhanced by

(A) Careful gender-sensitive probing of the respondent

(B) Engaging male-nurses to respond

(C) Engaging other female nurses to respond

(D) Engaging mother-in-laws to respond

8. ‘The Role of Medicine’ was written by

(A) Patricia Oberoi (B) Thomas McKeowa

(C) Shiela Zirbrigg (D) D. Banerjee

9. Work on social constructionism using ‘power’ and ‘knowledge’ was done by

(A) M. Foucault (B) I. Ellich

(C) B. Turner (D) T. Parsons

D-81-14 3 Paper-II

ÃÖÖ´ÖÖ×• ÖÛ ú † Öî ÂÖ×¬ Ö ‹¾ ÖÓ ÃÖÖ´Öã ¤ ü Ö×µÖÛ ú Ã¾ ÖÖÃ£µÖ

¯ÖÏ¿®Ö¯Ö¡Ö – II

×®Ö¤ìü¿Ö : ‡ÃÖ ¯ÖÏ¿®Ö¯Ö¡Ö ´Öë ¯Ö“ÖÖÃÖ (50) ²ÖÆãü-×¾ÖÛú»¯ÖßµÖ ¯ÖÏ¿®Ö Æïü … ¯ÖÏŸµÖêÛú ¯ÖÏ¿®Ö Ûêú ¤üÖê (2) †ÓÛú Æïü … ÃÖ³Öß ¯ÖÏ¿®Ö †×®Ö¾ÖÖµÖÔ Æïü …

1. ‹´Ö †Öê ‹“Ö ‹±ú ›ü²»µÖæ Ûêú ¯Öã®Ö¸üßõÖÞÖ Ûêú †®ŸÖÝÖÔŸÖ ×®Ö´®Ö×»Ö×ÜÖŸÖ ´Öë ÃÖê ÛúÖî®Ö ÃÖÖ ¯ÖÖêÂÖÞÖ ÛúÖµÖÔÛÎú´Ö †ÖŸÖÖ Æîü ?

(A) ¯ÖÖêÂÖÛú ¸üŒŸÖ †»¯ÖŸÖÖ Ûêú ×¾Ö¹ý¨ü ¸üÖêÝÖ ×®Ö¸üÖê¬Ö®Ö (B) ¤üÖê¯ÖÆü¸ü Ûêú ³ÖÖê•Ö®Ö ÛúÖ ÛúÖµÖÔÛÎú´Ö (C) †Ö‡Ô ÃÖß ›üß ‹ÃÖ ÛúÖµÖÔÛÎú´Ö (D) ×¾Ö¿ÖêÂÖ ¯ÖÖêÂÖÞÖ ÛúÖµÖÔÛÎú´Ö

2. ×ÛúÃÖ ¾ÖÂÖÔ ´Öë Ûêú®¦üßµÖ Ã¾ÖÖÃ£µÖ ÛúÖ Ó×ÃÖ»Ö Ûúß Ã£ÖÖ¯Ö®ÖÖ Ûúß ÝÖ‡Ô ×•ÖÃÖÛêú †¬µÖõÖ Ûêú®¦üßµÖ Ã¾ÖÖÃ£µÖ ´ÖÓ¡Öß £Öê †Öî ü ¸üÖ•µÖ Ã¾ÖÖÃ£µÖ ´ÖÓ¡Öß ˆÃÖÛêú ÃÖ¤üÃµÖ £Öê ?

(A) 1950 (B) 1952

(C) 1954 (D) 1957

3. ×®Ö´®Ö×»Ö×ÜÖŸÖ ´Öë ÃÖê ÛúÖî®Ö ÃÖÖ ŸÖ¢¾Ö ¯ÖÏÖ£Ö×´ÖÛú Ã¾ÖÖÃ£µÖ ÃÖê¾ÖÖ ÛúÖ ³ÖÖÝÖ ®ÖÆüà Æîü ?

(A) ™üßÛúÖÛú¸üÞÖ (B) ÃÖÖ´ÖÖ®µÖ ²Öß´ÖÖ×¸üµÖÖë ÛúÖ ˆ¯ÖµÖãŒŸÖ ‡»ÖÖ•Ö (C) ˆ¯ÖµÖãŒŸÖ ŸÖÛú®ÖßÛú (D) †Ö¾Ö¿µÖÛú ¤ü¾ÖÖ‹Ñ ˆ¯Ö»Ö²¬Ö Ûú¸ü¾ÖÖ®ÖÖ

4. ‘¤üß ÛÓú›üß¿Ö®ÃÖ †Öò±ú ¤ü ¾ÖÚÛúÝÖ Œ»ÖÖÃÖ ‡®Ö ‡ÓÝ»Öï›ü’ ×ÛúÃÖ®Öê ×»ÖÜÖß £Öß ?

(A) ‹. ×ÝÖ›üÃÖÔ (B) Ûêú. ´ÖÖŒÃÖÔ (C) ‹±ú. ‹Ó•Ö»ÃÖ (D) ‹›ü´Ö ×Ã´Ö£Ö

5. ³ÖÖ¸üŸÖ Ûúß ×ÛúÃÖ •Ö®ÖÝÖÞÖ®ÖÖ ´Öë †Ö×ÜÖÌ¸üß ²ÖÖ¸ü •ÖÖ×ŸÖ Ûêú ²ÖÖ¸êü ´Öë ¯Öæ”ûÖ ÝÖµÖÖ £ÖÖ ?

(A) 1941 (B) 1931

(C) 1911 (D) 1921

6. ²ÖÖµÖÖê ´Öê×›üÛú»Ö / •Öî¾Ö ×“Ö×ÛúŸÃÖÖ ÛúÖê •ÖÖ®Ö®Öê ÛúÖ †Ö¤ü¿ÖÔ Æîü (A) ÃÖÓÛú»Ö®Ö (B) ÃÖÛúÖ¸üÖŸ´ÖÛú (C) ¯ÖÏ×ŸÖ³ÖÖÝÖÖŸ´ÖÛú (D) ˆ¯ÖµÖãÔŒŸÖ ´Öë ÃÖê ÛúÖê‡Ô ®ÖÆüà

7. Ã¡Öß ¹ýÝÞÖŸÖÖ Ûúß ×¸ü¯ÖÖêÚ™üÝÖ ÛúÖê ²ÖœÌüÖ®Öê ¾ÖÖ»Öê Æïü (A) ¯ÖÏ×ŸÖ×ÛÎúµÖÖ ´Öë Ø»ÖÝÖ ÃÖÓ¾Öê¤üß •ÖÖÑ“Ö ´Öë ÃÖÖ¾Ö¬ÖÖ®Öß (B) ¯Öã¹ýÂÖ ®ÖÃÖÖí Ûúß ×®ÖµÖã×ŒŸÖ ¯ÖÏ×ŸÖ×ÛÎúµÖÖ ´Öë (C) Ã¡Öß ®ÖÃÖÖí Ûúß ×®ÖµÖã×ŒŸÖ ¯ÖÏ×ŸÖ×ÛÎúµÖÖ ´Öë (D) ´ÖÖŸÖÖ†Öë Ûúß ×®ÖµÖã×ŒŸÖ ¯ÖÏ×ŸÖ×ÛÎúµÖÖ ´Öë

8. ‘¤üß ¸üÖê»Ö †Öò±ú ´Öê×›ü×ÃÖ®Ö’ ×ÛúÃÖ®Öê ×»ÖÜÖß £Öß : (A) ¯Öî×™Òü×ÃÖµÖÖ †Öê²Öê¸üÖòµÖ (B) £ÖÖò´ÖÃÖ ´ÖîÛúŒµÖÖê®Ö (C) ¿Öß»ÖÖ •ûÌµÖæ¸ü²Ö×¸üÝÖ (D) ›üß. ²Öî®Ö•Öá

9. ‘ÃÖÖê¿Ö»Ö ÛÓúÃ™ÒüŒ¿Ö×®Ö•´Ö’ ´Öë ‘ÃÖ¢ÖÖ’ †Öî¸ü ‘–ÖÖ®Ö’ ÛúÖ ¯ÖÏµÖÖêÝÖ ×ÛúÃÖÛêú «üÖ¸üÖ ×ÛúµÖÖ ÝÖµÖÖ ? (A) ‹´Ö. ±æúÛúÖò»™ü (B) †Ö‡Ô. ‹×»Ö“Ö (C) ²Öß. ™ü®ÖÔ¸ü (D) ™üß. ¯ÖÖÃÖÔ®Ö

Paper-II 4 D-81-14

10. Pearl Index is related to measure of

(A) contraceptive efficacy (B) child nutrition

(C) maternal nutrition (D) infant mortality

11. Measures of group variability from sample to sample or sample to population involve

several steps :

I. Selection of sufficiently large and random sample.

II. Finding the probability or relative frequency of the sample.

III. Application of Standard Error differences

IV. Paired t-test

(A) I and II are true (B) I and III are true

(C) II and IV are true (D) III and IV are true

12. The immediate complications of menstrual regulation :

I. Uterine preforation

II. Infertility

III. Premature labour

IV. Uterine trauma

(A) I and II (B) II and III

(C) II and IV (D) I and IV

13. Criteria for causal-association are

I. Temporality II. Strength of association

III. Consistency IV. Probability

(A) I, II, III (B) III, IV

(C) I, II, IV (D) II, III, IV

14. Modes of direct transmission of agents of infectious diseases are

I. droplet infection II. droplet nuclei

III. transplacental IV. fomite-borne

(A) I, III, IV (B) II, IV

(C) I, IV (D) I, III

15. Which of the following statements are correct with regard to Malaria disease ?

I. Clinical features of malaria disease are the cold stage, hot stage and sweating stage.

II. Anti-malaria month is observed every year in the month of June in India.

III. There is a very effective vaccine for malaria.

IV. Malarial parasites are of two types only – Plasmodium vivax and Plasmodium

falciparum.

(A) I & II are correct. (B) II & III are correct.

(C) III & IV are correct. (D) I & IV are correct.

D-81-14 5 Paper-II

10. ¯Ö»ÖÔ ÃÖæ“ÖÛúÖÓÛú ÛúÖ ÃÖÓ²ÖÓ¬Ö Æîü (A) ÝÖ³ÖÔ ×®Ö¸üÖê¬ÖÛú õÖ´ÖŸÖÖ ÛúÖê ´ÖÖ¯Ö®Öê ÃÖê (B) ²ÖÖ»Ö ¯ÖÖêÂÖÞÖ ÛúÖê ´ÖÖ¯Ö®Öê ÃÖê (C) ´ÖÖŸÖÖ ÛúÖ ¯ÖÖêÂÖÞÖ ´ÖÖ¯Ö®Öê ÃÖê (D) ×¿Ö¿Öã ´ÖéŸµÖã¤ü¸ü ´ÖÖ¯Ö®Öê ÃÖê

11. ®Ö´Öæ®Öê ÃÖê ®Ö´Öæ®Öê †£Ö¾ÖÖ ®Ö´Öæ®Öê ÃÖê •Ö®ÖÃÖÓÜµÖÖ ´Öë ÃÖ´ÖæÆü ¯Ö×¸ü¾ÖŸÖÔ®Ö¿Öß»ÖŸÖÖ ÛúÖ ´ÖÖ¯Ö®Ö ×¾Ö×³Ö®®Ö “Ö¸üÞÖÖë ´Öë ÆüÖêŸÖÖ Æîü : I. ¯ÖµÖÖÔ¯ŸÖ ºþ¯Ö ÃÖê ²Ö›ÌüÖ †Öî¸ü Ã¾Öî×“”ûÛú ®Ö´Öæ®Öê ÛúÖ “ÖµÖ®Ö II. ÃÖÓ³ÖÖ¾µÖŸÖÖ †£Ö¾ÖÖ ®Ö´Öæ®Öê Ûúß ÃÖÓ²ÖÓ×¬ÖŸÖ ¯ÖÏÖ×µÖÛúŸÖÖ Ûúß ÜÖÖê•Ö Ûú¸ü®ÖÖ III. ´ÖÖ®ÖÛú ¡Öã×™ü Ûêú ÛúÖ¸üÞÖ Ûúß ¯ÖÏÖÃÖÓ×ÝÖÛúŸÖÖ IV. µÖã×Ý´ÖŸÖ ™üß ™êüÃ™ü (A) I †Öî¸ü II ÃÖÆüß Æïü … (B) I †Öî¸ü III ÃÖÆüß Æïü …

(C) II †Öî¸ü IV ÃÖÆüß Æï …ü (D) III †Öî¸ü IV ÃÖÆüß Æïü …

12. ´ÖÖ×ÃÖÛú ¸ü•ÖÖê¾Öé×¢Ö ÛúÖê ×®ÖµÖ×´ÖŸÖ Ûú¸ü®Öê ´Öë ŸÖÖŸÛúÖ×»ÖÛú •Ö×™ü»ÖŸÖÖ‹Ñ Æïü : I. ÝÖ³ÖÖÔ¿ÖµÖ ¾Öê¬Ö®Ö II. †®Öã¾ÖÔ¸üŸÖÖ III. ÃÖ´ÖµÖ¯Öæ¾ÖÔ ¯ÖÏÃÖ¾Ö IV. ÝÖ³ÖÖÔ¿ÖµÖ “ÖÖê™ü (A) I †Öî¸ü II ü (B) II †Öî¸ü III (C) II †Öî¸ü IVü (D) I †Öî¸ü IV

13. ÛúÖò•ÖÌ»Ö-‹ÃÖÖê×ÃÖ‹¿Ö®Ö Ûêú ×»Ö‹ ´ÖÖ¯Ö¤Óü›ü Æîü : I. †»¯ÖÛúÖ×»ÖÛúŸÖÖ II. ‹ÃÖÖê×ÃÖ‹¿Ö®Ö Ûúß ¿Ö×ŒŸÖ III. ÃÖÓÝÖ×ŸÖ IV. ÃÖÓ³ÖÖ¾µÖŸÖÖ (A) I, II, IIIü (B) III, IV

(C) I, II, IV (D) II, III, IV

14. ÃÖÓÛÎúÖ´Öß ²Öß´ÖÖ×¸üµÖÖë Ûêú ÃÖÓ¾ÖÖÆüÛúÖë ÛúÖ ÃÖß¬ÖÖ ÃÖÓ“ÖÖ¸üÞÖ ŸÖ¸üßÛúÖ Æîü : I. ×²Ö®¤ãüÛú ÃÖÓÛÎú´ÖÞÖ II. ×²Ö®¤ãüÛú ®ÖÖ×³ÖÛú III. ™ÒüÖÓÃÖ¯»ÖêÃÖê®™ü»Ö IV. ±úÖê´ÖÖ‡™ü-²ÖÖê®ÖÔ (A) I, III, IV (B) II, IV

(C) I, IV (D) I, III

15. ×®Ö´®Ö×»Ö×ÜÖŸÖ ´Öë ÃÖê ´Ö»Öê×¸üµÖÖ ²Öß´ÖÖ¸üß Ûêú ÃÖÓ²ÖÓ¬Ö ´Öë ÛúÖî®Ö ÃÖê Ûú£Ö®Ö ÃÖÆüß Æïü : I. ´Ö»Öê×¸üµÖÖ Ûêú »ÖõÖÞÖ šÓü›ü »ÖÝÖ®Öê Ûúß ×Ã£Ö×ŸÖ, ÝÖ´Öá »ÖÝÖ®Öê Ûúß ×Ã£Ö×ŸÖ ŸÖ£ÖÖ ¯ÖÃÖß®ÖÖ †Ö®Öê Ûúß ×Ã£Ö×ŸÖ II. ¯ÖÏ×ŸÖ¾ÖÂÖÔ ³ÖÖ¸üŸÖ ´Öë •Öæ®Ö Ûêú ´ÖÆüß®Öê ´Öë ‘‹Ó™üß ´Ö»Öê×¸üµÖÖ ´ÖÓ£Ö’ ´Ö®ÖÖµÖÖ •ÖÖŸÖÖ Æîü … III. ´Ö»Öê×¸üµÖÖ ÃÖê ²Ö“ÖÖ¾Ö Ûêú ×»Ö‹ ‹Ûú †ŸµÖÓŸÖ ¯ÖÏ³ÖÖ¾Ö¿ÖÖ»Öß ™üßÛúÖ ˆ¯Ö»Ö²¬Ö Æîü … IV. ´Ö»Öê×¸üµÖÖ ¯Ö¸ü•Öß¾Öß Ûêú¾Ö»Ö ¤üÖê ¯ÖÏÛúÖ¸ü Ûêú ÆüÖêŸÖê Æïü – ¯»ÖÖÃ´ÖÖê×›üµÖ´Ö ¾ÖÖ‡¾ÖîŒÃÖ ŸÖ£ÖÖ ¯»ÖÖÃ´ÖÖê×›üµÖ´Ö ±úÖò»ÃÖß¯Öê ü´Ö (A) I †Öî¸ü II ÃÖÆüß Æïü … (B) II †Öî¸ü III ÃÖÆüß Æïü …

(C) III †Öî¸ü IV ÃÖÆüß Æï …ü (D) I †Öî¸ü IV ÃÖÆüß Æïü …

Paper-II 6 D-81-14

16. Which of the following statements are true regarding International Organizations ?

I. The WHO has its origin in April 1945.

II. The Red Cross Society of India is an international NGO.

III. UNICEF is an organization looking for maternal and child health.

IV. The headquarters of WHO is in Geneva.

(A) I and II are correct. (B) I, II and III are correct.

(C) II, III and IV are correct. (D) I, III and IV are correct.

17. In occupational hazards, the following are the physical hazards :

I. Heat and Cold II. Ionizing Radiation

III. Industrial Neurosis IV. Ultraviolet Radiation

(A) II, III and IV are correct. (B) I, II and IV are correct.

(C) I, II and III are correct. (D) III, IV and I are correct.

18. Which of the following statements are correct ?

I. Vitamin D is stored largely in the fat depots of the body.

II. Deficiency of Vitamin C results in Scurvy.

III. The signs of Vitamin A deficiency are predominantly ocular.

IV. Beri-beri is caused by deficiency of Vitamin E.

(A) I, II and III are correct. (B) II, III and IV are correct.

(C) I, III and IV are correct. (D) I, II and IV are correct.

19. Which of the following statements regarding the Geriatrics community is true ?

I. Certain chronic diseases are more frequent among the older people than in the

younger people.

II. Ageing is an unnatural process.

III. HelpAge India is the largest voluntary organization working for the aged.

IV. Geriatric gynaecology is a new branch of specialization to look after the aged

women.


(C) III, IV and I are correct. (D) II, IV and I are correct.

20. The following three are the milestones of the National AIDS Control Programme :

I. In 1986, the first case of HIV was detected in India.

II. In 1989 the NACP was first set-up.

III. In 1992 NACO (National AIDS Control Organisation) was set up.

IV. In 2004, Anti-retroviral treatment was initiated under the NACO.


(C) I, III and IV are correct. (D) I, II and IV are correct.

D-81-14 7 Paper-II

16. ×®Ö´®Ö×»Ö×ÜÖŸÖ ´Öë ÃÖê ÛúÖî®Ö ÃÖê Ûú£Ö®Ö †ÓŸÖ¸üÖÔÂ™ÒüßµÖ ÃÖÓÃ£ÖÖ†Öë Ûêú ÃÖÓ²ÖÓ¬Ö ´Öë ÃÖÆüß Æïü : I. ›ü²»ÖµÖæ.‹“Ö.†Öê. Ûúß Ã£ÖÖ¯Ö®ÖÖ 1945 ´Öë Æãü‡Ô £Öß … II. ¸êü›ü ÛÎúÖòÃÖ ÃÖÖêÃÖÖ‡™üß †Öò±ú ‡Ó×›üµÖÖ ‹Ûú †ÓŸÖ¸üÖÔÂ™ÒüßµÖ ÃÖÓÃ£ÖÖ Æîü … III. µÖæ×®ÖÃÖê±ú ‹Ûú ÃÖÓÃ£ÖÖ Æîü •ÖÖê ´ÖÖŸÖÖ ŸÖ£ÖÖ ²Ö““ÖÖë Ûêú Ã¾ÖÖÃ£µÖ ÛúÖ ÜµÖÖ»Ö ¸üÜÖŸÖß Æîü … IV. ›ü²»µÖæ.‹“Ö.†Öê. ÛúÖ Æêü›üŒ¾ÖÖ™Ôü ü •Öê®Öê¾ÖÖ ´Öë Æîü …

(A) I †Öî¸ü II ÃÖÆüß Æïü … (B) I, II †Öî¸ü III ÃÖÆüß Æïü …

(C) II, III †Öî¸ü IV ÃÖÆüß Æïü … (D) I, III †Öî¸ü IV ÃÖÆüß Æïü …

17. ¾µÖÖ¾ÖÃÖÖ×µÖÛú ÜÖŸÖ¸üÖë ´Öë ×®Ö´®Ö×»Ö×ÜÖŸÖ ³ÖÖî×ŸÖÛú ÜÖŸÖ¸êü Æïü : I. ÝÖ´Öá †Öî¸ü šÓü›ü II. †ÖµÖ×®ÖŸÖ ×¾Ö×Ûú¸üÞÖ III. †ÖîªÖê×ÝÖÛú ®µÖæ üÖê×ÃÖÃÖ IV. ¯Ö¸üÖ²ÖïÝÖ®Öß ×¾Ö×Ûú¸üÞÖ (A) II, III †Öî¸ü IV ÃÖÆüß Æïü … (B) I, II †Öî¸ü IV ÃÖÆüß Æïü …

(C) I, II †Öî¸ü III ÃÖÆüß Æïü … (D) III, IV †Öî¸ü I ÃÖÆüß Æïü …

18. ×®Ö´®Ö×»Ö×ÜÖŸÖ ´Öë ÃÖê ÛúÖî®Ö ÃÖê Ûú£Ö®Ö ÃÖÆüß Æïü I. ×¾Ö™üÖ×´Ö®Ö ›üß Ûúß †×¬ÖÛúŸÖ´Ö ´ÖÖ¡ÖÖ ¿Ö¸üß¸ü Ûêú ¾ÖÃÖÖ ³ÖÓ›üÖ¸ü ´Öë ¯ÖÖµÖß •ÖÖŸÖß Æîü … II. ×¾Ö™üÖ×´Ö®Ö ‘ÃÖß’ Ûúß Ûú´Öß ÃÖê ‘ÃÛú¾Öá’ ÆüÖêŸÖß Æîü … III. ×¾Ö™üÖ×´Ö®Ö ‘‹’ Ûúß Ûú´Öß •ûÌµÖÖ¤üÖŸÖ¸ü ®Öê¡Ö ÃÖ´²ÖÓ¬Öß Æîü … IV. ‘²Öê¸üß ²Öê¸üß’ ×¾Ö™üÖ×´Ö®Ö ‘‡Ô’ Ûúß Ûú´Öß ÃÖê ÆüÖêŸÖÖ Æîü …

(A) I, II †Öî¸ü III ÃÖÆüß Æïü … (B) II, III †Öî¸ü IV ÃÖÆüß Æïü …

(C) I, III †Öî¸ü IV ÃÖÆüß Æïü … (D) I, II †Öî¸ü IV ÃÖÆüß Æïü …

19. ×®Ö´®Ö×»Ö×ÜÖŸÖ ´Öë ÃÖê ÛúÖî®Ö ÃÖê Ûú£Ö®Ö ¾Öé¨ü ÃÖ´Öã¤üÖµÖ Ûêú ×»Ö‹ ÃÖŸµÖ Æïü : I. Ûãú”û ¯Öã¸üÖ®Öß ²Öß´ÖÖ×¸üµÖÖÑ ¾Öé¨ü »ÖÖêÝÖÖë ´Öë µÖã¾ÖÖ†Öë ÃÖê †×¬ÖÛú ¯ÖÖ‡Ô •ÖÖŸÖß Æïü … II. †ÖµÖã ¾Öé×¨ü †¯ÖÏÖÛéú×ŸÖÛú ×ÛÎúµÖÖ Æîü … III. ‘Æîü»¯Ö‹•Ö ‡Ó×›üµÖÖ’ ¾Öé¨üÖë Ûêú ×»Ö‹ ÛúÖµÖÔ Ûú¸ü®Öê ¾ÖÖ»Öß ÃÖ²ÖÃÖê ²Ö›Ìüß Ã¾ÖµÖÓÃÖê¾Öß ÃÖÓÃ£ÖÖ Æîü … IV. ‘•Öß×¸üµÖî×™ÒüÛú ÝÖÖ‡®ÖêÛúÖê»ÖÖê•Öß’ ¾Öé¨ü ´Ö×Æü»ÖÖ†Öë Ûúß ¤êüÜÖ³ÖÖ»Ö Ûêú ×»Ö‹ ‹Ûú ®Ö‡Ô ×¾Ö¿ÖêÂÖ–ÖŸÖÖ ¿ÖÖÜÖÖ Æîü …


(C) III, IV †Öî¸ü I ÃÖÆüß Æïü … (D) II, IV †Öî¸ü I ÃÖÆüß Æïü …

20. ¸üÖÂ™ÒüßµÖ ‹›ËüÃÖ ×®ÖµÖÓ¡ÖÞÖ ÛúÖµÖÔÛÎú´Ö Ûúß ×®Ö´®Ö×»Ö×ÜÖŸÖ ŸÖß®Ö ˆ¯Ö»Ö×²¬ÖµÖÖÑ Æïü : I. 1986 ´Öë ‹“Ö †Ö‡Ô ¾Öß ÛúÖ ¯ÖÆü»ÖÖ ´ÖÖ´Ö»ÖÖ œæÑüœüÖ ÝÖµÖÖ … II. 1989 ´Öë ‹®Ö ‹ ÃÖß ¯Öß Ûúß ¯ÖÆü»Öß ²ÖÖ¸ü Ã£ÖÖ¯Ö®ÖÖ Æãü‡Ô … III. 1992 ´Öë ®ÖÖÛúÖê (¸üÖÂ™ÒüßµÖ ‹›ËüÃÖ ×®ÖµÖÓ¡ÖÞÖ ÃÖÓÝÖšü®Ö) Ã£ÖÖ×¯ÖŸÖ Æãü†Ö … IV. 2004 ´Öë ®ÖÖÛúÖê Ûêú †ÓŸÖÝÖÔŸÖ ‹Ó™üß-×¸ü™ÒüÖê¾ÖÖ‡¸ü»Ö ˆ¯Ö“ÖÖ¸ü ¯ÖÏÖ¸Óü³Ö Æãü†Ö …


(C) I, III †Öî¸ü IV ÃÖÆüß Æïü … (D) I, II †Öî¸ü IV ÃÖÆüß Æïü …

Paper-II 8 D-81-14

21. Assertion (A) : Toxic Shock Syndrome (TSS) can occur if measles vaccines are

contaminated with Staphylococcus aureus.

Reason (R) : TSS T-1 causes TSS.

(A) Both (A) and (R) are true and (R) is the correct explanation of (A).

(B) Both (A) and (R) are true, but (R) is not the correct explanation of (A).

(C) (A) is true, but (R) is false.

(D) (A) is false, but (R) is true.

22. Assertion (A) : Roll Back Malaria (RBM) sets targets of > 80% coverage for four key

interventions.

Reason (R) : Global Fund for AIDS, TB and Malaria (GFATM) was established in 2002.





23. Assertion (A) : Global Action Plan for Pneumonia (GAPP) was proposed by WHO in

2006.

Reason (R) : GAPP addresses multi-dimensional strategies for control of pneumonia.





24. Assertion (A) : IMNCI guidelines address needs of children aged less than 3 years.

Reason (R) : IMNCI uses a syndromic approach.





25. Assertion (A) : Risk of chronic complications are higher in type 2 Diabetes Mellitus than

Type 1 Diabetes Mellitus.

Reason (R) : ‘Honeymoon phase’ is a feature seen is Type 1 Diabetes Mellitus.





D-81-14 9 Paper-II

21. †×³ÖÛ ú£ Ö® Ö (A ) : †ÝÖ¸ü ÜÖÃÖ¸üÖ Ûúß ÃÖã‡Ô ÝÖã“”ûÖÞÖã †Öò×¸üµÖÃÖ ÃÖê ÃÖÓ¤æü×ÂÖŸÖ ÆüÖê •ÖÖ‹ ŸÖÖê ™üÖò×ŒÃÖÛú ¿ÖÖòÛú ×ÃÖ®›ÒüÖò´Ö (TSS) ÆüÖê ÃÖÛúŸÖÖ Æîü …

Û úÖ¸ü ÞÖ (R ) : TSS T-1 ÃÖê TSS ÆüÖêŸÖÖ Æîü …

(A) (A) †Öî¸ü (R) ¤üÖê®ÖÖë ÃÖÆüß Æïü ŸÖ£ÖÖ (R), (A) Ûúß ÃÖÆüß ¾µÖÖÜµÖÖ Æîü … (B) (A) ŸÖ£ÖÖ (R) ¤üÖê®ÖÖë ÃÖÆüß Æïü, ¯Ö¸ÓüŸÖã (R), (A) Ûúß ÃÖÆüß ¾µÖÖÜµÖÖ ®ÖÆüà Æîü …

(C) (A) ÃÖÆüß Æîü, ¯Ö¸ÓüŸÖã (R) ÝÖ»ÖŸÖ Æîü … (D) (A) ÝÖ»ÖŸÖ Æîü, ¯Ö ÓüŸÖã (R) ÃÖÆüß Æîü …

22. †×³ÖÛ ú£ Ö® Ö (A ) : “ÖÖ¸ü ¯ÖÏ´ÖãÜÖ ´Ö¬µÖÃ£ÖŸÖÖ Ûúß ÝÖÞÖ®ÖÖ Ûú¸ü®Öê Ûêú ×»Ö‹ ¸üÖò»Ö ²ÖîÛú ´Ö»Öê×¸üµÖÖ (RBM) ≥ 80% ÛúÖ »ÖõµÖ ×®Ö¬ÖÖÔ×¸üŸÖ Ûú¸üŸÖÖ Æîü …

Û úÖ¸ü ÞÖ (R ) : ‹›ËüÃÖ, ™üß.²Öß. †Öî ü ´Ö»Öê× üµÖÖ ÆêüŸÖã Ý»ÖÖê²Ö»Ö ±úÞ›ü (GFATM) ÛúÖ ×®Ö´ÖÖÔÞÖ ¾ÖÂÖÔ 2002 ´Öë ×ÛúµÖÖ ÝÖµÖÖ …



23. †×³ÖÛ ú£ Ö® Ö (A ) : ×®Ö´ÖÖê×®ÖµÖÖ ÆêüŸÖã Ý»ÖÖê²Ö»Ö ‹Œ¿Ö®Ö ¯»ÖÖ®Ö (GAPP) ÛúÖê ×¾Ö¿¾Ö Ã¾ÖÖÃ£µÖ ÃÖÓÝÖšü®Ö (WHO) «üÖ¸üÖ ¾ÖÂÖÔ 2006 ´Öë ¯ÖÏÃŸÖÖ×¾ÖŸÖ ×ÛúµÖÖ ÝÖµÖÖ …

Û úÖ¸ü ÞÖ (R ) : ×®Ö´ÖÖê×®ÖµÖÖ Ûêú ×®ÖµÖÓ¡ÖÞÖ ÆêüŸÖã GAPP ×¾Ö×¾Ö¬Ö ˆ¯ÖÖµÖ ÃÖã—ÖÖŸÖÖ Æîü …



24. †×³ÖÛ ú£ Ö® Ö (A ) : †Ö‡Ô.‹´Ö.‹®Ö.ÃÖß.†Ö‡Ô. Ûêú ×¤ü¿ÖÖ-×®Ö¤ìü¿Ö 3 ¾ÖÂÖÔ ÃÖê Ûú´Ö ˆ´ÖÏ Ûêú ²Ö““ÖÖë Ûúß †Ö¾Ö¿µÖÛúŸÖÖ†Öë ÛúÖê ¯Öæ üÖ Ûú¸üŸÖê Æïü …

Û úÖ¸ü ÞÖ (R ) : †Ö‡Ô.‹´Ö.‹®Ö.ÃÖß.†Ö‡Ô. ×ÃÖ®›ÒüÖò×´ÖÛú ×¾Ö×¬Ö ÛúÖê †¯Ö®ÖÖŸÖÖ Æîü …



25. †×³ÖÛ ú£ Ö® Ö (A ) : ™üÖ‡¯Ö-1 ´Ö¬Öã´ÖêÆü ´Öê»ÖÖ‡™üÃÖ Ûêú ´ÖãÛúÖ²Ö»Öê ™üÖ‡¯Ö-2 ´Ö¬Öã´ÖêÆü ´Öê»ÖÖ‡™üÃÖ ´Öë »ÖÓ²Öß •Ö×™ü»ÖŸÖÖ†Öë ÛúÖ •ÖÖê×ÜÖ´Ö †×¬ÖÛú ÆüÖêŸÖÖ Æîü …

Û úÖ¸ü ÞÖ (R ) : ™üÖ‡¯Ö-1 ´Ö¬Öã´ÖêÆü ´Öê»ÖÖ‡™üÃÖ ´Öë ‘Æü®Öß´Öæ®Ö ±êú•ÖÌ’ ÛúÖ ‹Ûú »ÖõÖÞÖ ¯ÖÖµÖÖ •ÖÖŸÖÖ Æîü …



Paper-II 10 D-81-14

26. Assertion (A) : Pasteurisation of milk is a sterilization process.

Reason (R) : Its purpose is to destroy all the pathogenic organisms.





27. Assertion (A) : Birth dose of Hepatitis B vaccine can be given to new born within 24

hours.

Reason (R) : The birth dose of Hepatitis B vaccine is effective in preventing perinatal

transmission of hepatitis B if given within the first 24 hours.





28. Assertion (A) : Hepatitis B vaccine should be stored at 2 – 8 °C and freezing must be

avoided.

Reason (R) : Freezing process dissociates antigen from the alum adjuvant.





29. Assertion (A) : Yaws is transmitted by sexual route.

Reason (R) : Yaws is an endemic disease.





30. Assertion (A) : Copper T (IUD) insertion can be taken up during the 1st week after the

delivery.

Reason (R) : Special care is required with insertion because of the greater risk of

perforation during this time.





D-81-14 11 Paper-II

26. †×³ÖÛ ú£ Ö® Ö (A ) : ¤æü¬Ö ÛúÖ ¯ÖÖÃŸÖã¸üßÛú¸üÞÖ ‹Ûú •Öß¾ÖÖÞÖã®ÖÖ¿Ö®Ö ¯ÖÏ×ÛÎúµÖÖ Æîü … Û úÖ¸ü ÞÖ (R ) : ‡ÃÖÛúÖ ˆ§êü¿µÖ ¸üÖêÝÖ´Öæ»ÖÛú •Öß¾ÖÖë ÛúÖê ®ÖÂ™ü Ûú¸ü®ÖÖ Æîü …

(A) (A) †Öî¸ü (R) ¤üÖê®ÖÖë ÃÖÆüß Æïü ŸÖ£ÖÖ (R), (A) Ûúß ÃÖÆüß ¾µÖÖÜµÖÖ Æîü …

(B) (A) ŸÖ£ÖÖ (R) ¤üÖê®ÖÖë ÃÖÆüß Æïü, ¯Ö¸ÓüŸÖã (R), (A) Ûúß ÃÖÆüß ¾µÖÖÜµÖÖ ®ÖÆüà Æîü …

(C) (A) ÃÖÆüß Æîü, ¯Ö¸ÓüŸÖã (R) ÝÖ»ÖŸÖ Æîü …

(D) (A) ÝÖ»ÖŸÖ Æîü, ¯Ö ÓüŸÖã (R) ÃÖÆüß Æîü …

27. †×³ÖÛ ú£ Ö® Ö (A ) : Æîü¯Öê™üÖ‡×™üÃÖ-B ÃÖã‡Ô ÛúÖ ²Ö£ÖÔ ›üÖê•ÖÌ ®Ö¾Ö•ÖÖŸÖ ×¿Ö¿Öã ÛúÖê 24 ‘ÖÓ™êü Ûêú ³ÖßŸÖ¸ü ×¤üµÖÖ •ÖÖ ÃÖÛúŸÖÖ Æîü … Û úÖ¸ü ÞÖ (R ) : Æîü¯Öê™üÖ‡×™üÃÖ-B ÛúÖ ²Ö£ÖÔ ›üÖê•Ö Æîü¯Öê™üÖ‡×™üÃÖ-B Ûêú ¯Öî¸üß®Öê™ü»Ö ™ÒüÖÓÃÖ×´Ö¿Ö®Ö ÛúÖê ¸üÖêÛú®Öê ´Öë ¯ÖÏ³ÖÖ¾ÖÛúÖ¸üß ÆüÖêŸÖÖ

Æîü, †ÝÖ¸ü ¾ÖÆü ¯ÖÆü»Öê 24 ‘ÖÓ™êü Ûêú †Ó¤ü¸ü ×¤üµÖÖ •ÖÖ‹ …





28. †×³ÖÛ ú£ Ö® Ö (A ) : Æîü¯Öê™üÖ‡×™üÃÖ-B ™üßÛêú ÛúÖê 2° – 8° C ¯Ö¸ü ¸üÜÖÖ •ÖÖ®ÖÖ “ÖÖ×Æü‹ †Öî ü ×±ÏúØ•ÖÝÖ ÛúÖê †Ö¾Ö¿µÖÛú ºþ¯Ö ÃÖê ¸üÖêÛú®ÖÖ “ÖÖ×Æü‹ …

Û úÖ¸ü ÞÖ (R ) : ×±ÏúØ•ÖÝÖ ¯ÖÏ×ÛÎúµÖÖ ×±ú™üÛú¸üß ÃÖÆüÖîÂÖ¬ÖÃÖê ¯ÖÏ×ŸÖ•Ö®Öü ÛúÖê ¯Öé£ÖÛú Ûú¸ü ¤êüŸÖß Æîü …





29. †×³ÖÛ ú£ Ö® Ö (A ) : ¯ÖÏ•Ö®Ö®Ö ´ÖÖÝÖÔ Ûêú «üÖ¸üÖ µÖÖò•ÖÌ (Yaws) ±îú»ÖŸÖÖ Æîü … Û úÖ¸ü ÞÖ (R ) : µÖÖò•ÖÌ (Yaws) ‹Ûú Ã£ÖÖ×®ÖÛú ²Öß´ÖÖ¸üß Æîü …





30. †×³ÖÛ ú£ Ö® Ö (A ) : ×›ü×»Ö¾Ö¸üß Ûêú ˆ¯Ö¸üÖÓŸÖ ¯ÖÆü»Öê ÃÖ¯ŸÖÖÆü Ûêú ¤üÖî¸üÖ®Ö ÛúÖò¯Ö¸ü-™üß (IUD) ÛúÖê »ÖÝÖ¾ÖÖµÖÖ •ÖÖ ÃÖÛúŸÖÖ Æîü … Û úÖ¸ü ÞÖ (R ) : ‡ÃÖê »ÖÝÖÖŸÖê ÃÖ´ÖµÖ ×¾Ö¿ÖêÂÖ ÃÖÖ¾Ö¬ÖÖ®Öß ²Ö¸üŸÖ®Öê Ûúß †Ö¾Ö¿µÖÛúŸÖÖ ÆüÖêŸÖß Æîü ŒµÖÖë×Ûú ‡ÃÖ ¤üÖî¸üÖ®Ö ”êû¤ü®Ö ÛúÖ

²Ö›ÌüÖ •ÖÖê×ÜÖ´Ö ÆüÖêŸÖÖ Æîü …





Paper-II 12 D-81-14

31. Arrange the following States in order of institutional deliveries (lowest to highest) as

reported in DLHS-III :

(A) Andhra Pradesh, Jharkhand, Rajasthan, Kerala

(B) Kerala, Andhra Pradesh, Rajasthan, Jharkhand

(C) Jharkhand, Andhra Pradesh, Rajasthan, Kerala

(D) Jharkhand, Rajasthan, Andhra Pradesh, Kerala

32. What is the correct sequence of data analysis of qualitative data ?

(A) Domain identification, Free-listing, Familiarisation, Emergence of Model

(B) Free-listing, Emergence of model, Domain identification, Familiarisation

(C) Familiarisation, Free-listing, Domain-identification, Emergence of Model

(D) Emergence of model, Familiarisation, Domain-identification, Free-listing

33. As per 2006-07 National Survey on Blindness in India, arrange the causes of blindness

from low to high percentage :

(A) Refractive error, Glaucoma, Corneal opacity, Cataract

(B) Corneal opacity, Glaucoma, Refractive error, Cataract

(C) Cataract, Refractive error, Corneal opacity, Glaucoma

(D) Glaucoma, Refractive error, Corneal opacity, Cataract

34. Arrange the following milk/milk products (per 100 ml/100 g) in terms of fat content

(ascending order) :

(A) Milk (human), Milk (buffalo), Curd (cow’s milk), Cheese

(B) Cheese, Milk (human), Curd (cow’s milk), Milk (buffalo)

(C) Milk (human), Curd (cow’s milk), Milk (buffalo), Cheese

(D) Curd (cow’s milk), Milk (human), Cheese, Milk (buffalo)

35. Arrange the following health events in chronological order as per their occurrence :

(A) Launching of NACP I by Govt. of India, Return of plague in India, Emergence of

SARS in India, Declaration of India as guinea worm free

(B) Return of plague in India, Declaration of India as guinea worm free, Emergence of

SARS in India, Launching of NACP I by Govt. of India.

(C) Launching of NACP I by Govt. of India, Return of plague in India, Declaration of

India as guinea worm free, Emergence of SARS in India.

(D) Emergence of SARS in India, Return of plague in India, Declaration of India as

guinea worm free, Launching of NACP I by Govt. of India

36. Arrange the following malaria endemicity terminologies, based on ascending order

(lowest to highest) of spleen rates :

(A) Holoendemic, Hyperendemic, Mesoendemic, Hypoendemic

(B) Hypoendemic, Mesoendemic, Hyperendemic, Holoendemic

(C) Hypoendemic, Holoendemic, Mesoendemic, Hyperendemic

(D) Mesoendemic, Holoendemic, Hypoendemic, Hyperendemic

D-81-14 13 Paper-II

31. ×®Ö´®Ö×»Ö×ÜÖŸÖ ¸üÖ•µÖÖë ÛúÖê ›üß ‹»Ö ‹“Ö ‹ÃÖ III Ûúß ×¸ü¯ÖÖê™Ôü Ûêú †®ÖãÃÖÖ¸ü ÃÖÓÃ£ÖÖ×®ÖÛú ×¾ÖŸÖ¸üÞÖ (ÃÖ²ÖÃÖê ®Öß“Öê ÃÖê ÃÖ²ÖÃÖê ‰ú¯Ö¸ü) Ûêú ÛÎú´Ö ´Öë ¾µÖ¾Ö×Ã£ÖŸÖ Ûú¸ëü :

(A) †ÖÓ¬ÖÐ ¯ÖÏ¤êü¿Ö, —ÖÖ¸üÜÖÓ›ü, ¸üÖ•ÖÃ£ÖÖ®Ö, Ûêú¸ü»Ö (B) Ûêú¸ü»Ö, †ÖÓ¬ÖÐ ¯ÖÏ¤êü¿Ö, ¸üÖ•ÖÃ£ÖÖ®Ö, —ÖÖ¸üÜÖÓ›ü (C) —ÖÖ¸üÜÖÓ›ü, †ÖÓ¬ÖÐ ¯ÖÏ¤êü¿Ö, ¸üÖ•ÖÃ£ÖÖ®Ö, Ûêú¸ü»Ö (D) —ÖÖ¸üÜÖÓ›ü, ¸üÖ•ÖÃ£ÖÖ®Ö, †ÖÓ¬ÖÐ ¯ÖÏ¤êü¿Ö, Ûêú¸ü»Ö

32. ÝÖãÞÖ¾Ö¢ÖÖ¯Ö¸üÛú †ÖÑÛú›ÌüÖë Ûêú †ÖÑÛú›ÌüÖ ×¾Ö¿»ÖêÂÖÞÖ ÛúÖ ÃÖÆüß ÛÎú´Ö ŒµÖÖ Æîü ?

(A) ¯ÖÏ³ÖÖ¾Ö-õÖê¡Ö Ûúß ¯ÖÆü“ÖÖ®Ö, Ã¾ÖŸÖÓ¡Ö ÃÖÖ¸üÞÖßµÖÞÖ, ¯Ö×¸ü×“ÖŸÖ Ûú¸üÖ®ÖÖ, ¯ÖÏ×ŸÖ´ÖÖ®ÖÖë ÛúÖ ×®ÖÝÖÔ´Ö®Ö (B) Ã¾ÖŸÖÓ¡Ö ÃÖÖ¸üÞÖßµÖÞÖ, ¯ÖÏ×ŸÖ´ÖÖ®ÖÖë ÛúÖ ×®ÖÝÖÔ´Ö®Ö, ¯ÖÏ³ÖÖ¾Ö-õÖê¡Ö Ûúß ¯ÖÆü“ÖÖ®Ö, ¯Ö×¸ü×“ÖŸÖ Ûú¸üÖ®ÖÖ (C) ¯Ö×¸ü×“ÖŸÖ Ûú¸üÖ®ÖÖ, Ã¾ÖŸÖÓ¡Ö ÃÖÖ¸üÞÖßµÖÞÖ, ¯ÖÏ³ÖÖ¾Ö-õÖê¡Ö Ûúß ¯ÖÆü“ÖÖ®Ö, ¯ÖÏ×ŸÖ´ÖÖ®Ö ÛúÖ ×®ÖÝÖÔ´Ö®Ö (D) ¯ÖÏ×ŸÖ´ÖÖ®Ö ÛúÖ ×®ÖÝÖÔ´Ö®Ö, ¯Ö×¸ü×“ÖŸÖ Ûú¸üÖ®ÖÖ, ¯ÖÏ³ÖÖ¾Ö-õÖê¡Ö Ûúß ¯ÖÆü“ÖÖ®Ö, Ã¾ÖŸÖÓ¡Ö ÃÖÖ¸üÞÖßµÖÞÖ

33. †Ó¬ÖŸÖÖ ¯Ö¸ü ³ÖÖ¸üŸÖ ´Öë 2006-07 Ûêú ¸üÖÂ™ÒüßµÖ ÃÖ¾ÖìõÖÞÖ Ûêú †®ÖãÃÖÖ¸ü †Ó¬ÖŸÖÖ Ûêú ÛúÖ¸üÞÖÖë ÛúÖê ×®Ö´®Ö ÃÖê †×¬ÖÛú Ûêú ÛÎú´Ö ´Öë ¾µÖ¾Ö×Ã£ÖŸÖ Ûú¸ëü …

(A) ×¸ü±Ïêú×Œ™ü¾Ö ‹¸ü¸ü, Ý»ÖæÛúÖê´ÖÖ, ÛúÖÙ®ÖµÖ»Ö †Öê¯ÖÖ×ÃÖ™üß, Ûîú™ü îüŒ™ü (B) ÛúÖÙ®ÖµÖ»Ö †Öê¯ÖÖ×ÃÖ™üß, Ý»ÖæÛúÖê´ÖÖ, ×¸ü±Ïêú×Œ™ü¾Ö ‹¸ü¸ü, Ûîú™ü¸îüŒ™ü (C) Ûîú™ü¸îüŒ™ü, ×¸ü±Ïêú×Œ™ü¾Ö ‹¸ü¸ü, ÛúÖÙ®ÖµÖ»Ö †Öê¯ÖÖ×ÃÖ™üß, Ý»ÖæÛúÖê´ÖÖ (D) Ý»ÖæÛúÖê´ÖÖ, ×¸ü±Ïêú×Œ™ü¾Ö ‹¸ü¸ü, ÛúÖÙ®ÖµÖ»Ö †Öê¯ÖÖ×ÃÖ™üß, Ûîú™ü îüŒ™ü

34. ×®Ö´®Ö×»Ö×ÜÖŸÖ ¤æü¬Ö/¤æü¬Ö ˆŸ¯ÖÖ¤ü ÛúÖê (¯ÖÏ×ŸÖ 100 ×´Ö.ÝÖÏÖ./100 ÝÖÏÖ.) ¾ÖÃÖÖ ŸÖ¢¾Ö Ûêú †Ö¬ÖÖ¸ü ¯Ö¸ü †Ö¸üÖêÆüß ÛÎú´Ö ´Öë ¾µÖ¾Ö×Ã£ÖŸÖ Ûú¸ëü …

(A) ¤æü¬Ö (´ÖÖ®Ö¾Ö), ¤æü¬Ö (³ÖïÃÖ), ¤üÆüß (ÝÖÖµÖ Ûêú ¤æü¬Ö ÛúÖ), ¯Ö®Öß¸ü (B) ¯Ö®Öß¸ü, ¤æü¬Ö (´ÖÖ®Ö¾Ö), ¤üÆüß (ÝÖÖµÖ Ûêú ¤æü¬Ö ÛúÖ), ¤æü¬Ö (³ÖïÃÖ) (C) ¤æü¬Ö (´ÖÖ®Ö¾Ö), ¤üÆüß (ÝÖÖµÖ Ûêú ¤æü¬Ö ÛúÖ), ¤æü¬Ö (³ÖïÃÖ), ¯Ö®Öß¸, (D) ¤üÆüß (ÝÖÖµÖ Ûêú ¤æü¬Ö ÛúÖ), ¤æü¬Ö (´ÖÖ®Ö¾Ö), ¯Ö®Öß¸ü, ¤æü¬Ö (³ÖïÃÖ)

35. ×®Ö´®Ö×»Ö×ÜÖŸÖ Ã¾ÖÖÃ£µÖ ÛúÖµÖÔÛÎú´ÖÖë ÛúÖê ˆ®ÖÛêú ÆüÖê®Öê Ûêú ÛúÖ»ÖÖ®ÖãÛÎú×´ÖÛú ÛÎú´Ö ´Öë ¾µÖ¾Ö×Ã£ÖŸÖ Ûú¸ëü : (A) ³ÖÖ¸üŸÖ ÃÖ¸üÛúÖ¸ü «üÖ¸üÖ ‹®Ö ‹ ÃÖß ¯Öß I ÛúÖ ¿Öã³ÖÖ Óü³Ö, ¯»ÖêÝÖ Ûúß ³ÖÖ¸üŸÖ ´Öë ¾ÖÖ¯ÖÃÖß, ‹ÃÖ ‹ †Ö¸ü ‹ÃÖ ÛúÖ ³ÖÖ¸üŸÖ ´Öë

†ÖÝÖ´Ö®Ö, ×ÝÖ®Öß Ûúß›ÌüÖ ´ÖãŒŸÖ ³ÖÖ¸üŸÖ Ûúß ‘ÖÖêÂÖÞÖÖ (B) ¯»ÖêÝÖ Ûúß ³ÖÖ¸üŸÖ ´Öë ¾ÖÖ¯ÖÃÖß, ×ÝÖ®Öß Ûúß›ÌüÖ ´ÖãŒŸÖ ³ÖÖ¸üŸÖ Ûúß ‘ÖÖêÂÖÞÖÖ, ³ÖÖ¸üŸÖ ´Öë ‹ÃÖ ‹ †Ö¸ü ‹ÃÖ ÛúÖ †ÖÝÖ´Ö®Ö, ³ÖÖ¸üŸÖ

ÃÖ¸üÛúÖ¸ü «üÖ¸üÖ ‹®Ö ‹ ÃÖß ¯Öß I ÛúÖ ¿Öã³ÖÖ Óü³Ö (C) ³ÖÖ¸üŸÖ ÃÖ¸üÛúÖ¸ü «üÖ¸üÖ ‹®Ö ‹ ÃÖß ¯Öß I ÛúÖ ¿Öã³ÖÖ¸Óü³Ö, ¯»ÖêÝÖ Ûúß ³ÖÖ¸üŸÖ ´Öë ¾ÖÖ¯ÖÃÖß, ×ÝÖ®Öß Ûúß›ÌüÖ ´ÖãŒŸÖ ³ÖÖ¸üŸÖ Ûúß

‘ÖÖêÂÖÞÖÖ, ³ÖÖ¸üŸÖ ´Öë ‹ÃÖ ‹ †Ö¸ü ‹ÃÖ ÛúÖ †ÖÝÖ´Ö®Ö (D) ‹ÃÖ ‹ †Ö¸ü ‹ÃÖ ÛúÖ ³ÖÖ¸üŸÖ ´Öë †ÖÝÖ´Ö®Ö, ¯»ÖêÝÖ Ûúß ³ÖÖ¸üŸÖ ´Öë ¾ÖÖ¯ÖÃÖß, ×ÝÖ®Öß Ûúß›ÌüÖ ´ÖãŒŸÖ ³ÖÖ¸üŸÖ Ûúß ‘ÖÖêÂÖÞÖÖ, ³ÖÖ¸üŸÖ

ÃÖ¸üÛúÖ¸ü «üÖ¸üÖ ‹®Ö ‹ ÃÖß ¯Öß I ÛúÖ ¿Öã³ÖÖ Óü³Ö

36. ´Ö»Öê× üµÖÖ Ûúß ×®Ö´®Ö×»Ö×ÜÖŸÖ Ã£ÖÖ×®ÖÛú ¿Ö²¤üÖ¾Ö»Öß ÛúÖê ×ŸÖ»»Öß Ûêú ²ÖœÌü®Öê Ûêú †Ö¬ÖÖ ü ¯Ö ü (®Öß“Öê ÃÖê ÃÖ²ÖÃÖê ‰ú¯Ö ü) ¾µÖ¾Ö×Ã£ÖŸÖ Ûú ëü : (A) ÆüÖê»ÖÖê‹®Ö›êü×´ÖÛú, ÆüÖ‡¯Ö¸ü‹®Ö›êü×´ÖÛú, ´ÖêÃÖÖê‹®Ö›êü×´ÖÛú, ÆüÖ‡¯ÖÖê‹®Ö›êü×´ÖÛú (B) ÆüÖ‡¯ÖÖê‹®Ö›êü×´ÖÛú, ´ÖêÃÖÖê‹®Ö›êü×´ÖÛú, ÆüÖ‡¯Ö¸ü‹®Ö›êü×´ÖÛú, ÆüÖê»ÖÖê‹®Ö›êü×´ÖÛú (C) ÆüÖ‡¯ÖÖê‹®Ö›êü×´ÖÛú, ÆüÖê»ÖÖê‹®Ö›êü×´ÖÛú, ´ÖêÃÖÖê‹®Ö›êü×´ÖÛú, ÆüÖ‡¯Ö¸ü‹®Ö›êü×´ÖÛú (D) ´ÖêÃÖÖê‹®Ö›êü×´ÖÛú, ÆüÖê»ÖÖê‹®Ö›êü×´ÖÛú, ÆüÖ‡¯ÖÖê‹®Ö›êü×´ÖÛú, ÆüÖ‡¯Ö¸ü‹®Ö›êü×´ÖÛú

Paper-II 14 D-81-14

37. Choose the correct sequence of procedures in Descriptive Studies in Epidemiology :

(A) (i) Defining the population to be studied.

(ii) Describing the disease by time, place and person.

(iii) Defining the disease under study

(iv) measurement of disease

(B) (i) Defining the population to be studied.

(ii) Defining the disease under study.

(iii) Describing the disease by time, place and person.

(iv) Measurement of disease.

(C) (i) Measurement of Disease.

(ii) Describing the disease by time, place and person.

(iii) Defining the disease under study.

(iv) Defining the population to be studied.

(D) (i) Defining the population to be studied.

(ii) Defining the disease under study.

(iii) Measurement of Disease.

(iv) Describing the disease by time, place and person.

38. Arrange the symptomatology of SARS in descending order of frequency :

(A) Fever > 38 °C, sore throat, rigor, headache

(B) Fever > 38 °C, headache, rigor, sore throat

(C) Fever > 38 °C, sore throat, headache, rigor

(D) Fever > 38 °C, rigor, headache, sore throat

39. Arrange the following modes / routes of transmission of HIV in descending order of

probability(highest to lowest) :

(A) Blood transfusion, sexual intercourse, perinatal, mucous membrane

(B) Blood transfusion, perinatal, sexual intercourse, mucous membrane

(C) Mucous membrane, perinatal, sexual intercourse, blood transfusion

(D) Blood transfusion, mucous membrane, perinatal, sexual intercourse

D-81-14 15 Paper-II

37. ¸üÖêÝÖ ×¾Ö–ÖÖ®Ö Ûêú ×¾Ö¾Ö¸üÞÖÖŸ´ÖÛú †¬µÖµÖ®Ö ´Öë ¯ÖÏ×ÛÎúµÖÖ†Öë Ûêú ÃÖÆüß ÛÎú´Ö ÛúÖê ¯ÖÆü“ÖÖ×®Ö‹ :

(A) (i) ×•ÖÃÖÛúÖ †¬µÖµÖ®Ö ×ÛúµÖÖ •ÖÖ®ÖÖ Æîü ˆÃÖ •Ö®ÖÃÖÓÜµÖÖ ÛúÖê ¯Ö×¸ü³ÖÖ×ÂÖŸÖ Ûú ü®ÖÖ

(ii) ÃÖ´ÖµÖ, Ã£ÖÖ®Ö ¾Ö ¾µÖ×ŒŸÖ Ûêú †®ÖãÃÖÖ¸ü ¸üÖêÝÖ ÛúÖ ¾ÖÞÖÔ®Ö Ûú¸ü®ÖÖ

(iii) †¬µÖµÖ®Ö Ûêú †®ŸÖÝÖÔŸÖ ¸üÖêÝÖ ÛúÖê ¯Ö×¸ü³ÖÖ×ÂÖŸÖ Ûú¸ü®ÖÖ

(iv) ¸üÖêÝÖ ÛúÖ ´ÖÖ¯Ö®Ö

(B) (i) ×•ÖÃÖÛúÖ †¬µÖµÖ®Ö ×ÛúµÖÖ •ÖÖ®ÖÖ Æîü ˆÃÖ •Ö®ÖÃÖÓÜµÖÖ ÛúÖê ¯Ö×¸ü³ÖÖ×ÂÖŸÖ Ûú ü®ÖÖ

(ii) †¬µÖµÖ®Ö Ûêú †®ŸÖÝÖÔŸÖ ¸üÖêÝÖ ÛúÖê ¯Ö×¸ü³ÖÖ×ÂÖŸÖ Ûú¸ü®ÖÖ

(iii) ÃÖ´ÖµÖ, Ã£ÖÖ®Ö ¾Ö ¾µÖ×ŒŸÖ Ûêú †®ÖãÃÖÖ¸ü ¸üÖêÝÖ ÛúÖ ¾ÖÞÖÔ®Ö Ûú¸ü®ÖÖ

(iv) ¸üÖêÝÖ ÛúÖ ´ÖÖ¯Ö®Ö

(C) (i) ¸üÖêÝÖ ÛúÖ ´ÖÖ¯Ö®Ö

(ii) ÃÖ´ÖµÖ, Ã£ÖÖ®Ö ¾Ö ¾µÖ×ŒŸÖ Ûêú †®ÖãÃÖÖ¸ü ¸üÖêÝÖ ÛúÖ ¾ÖÞÖÔ®Ö Ûú¸ü®ÖÖ

(iii) †¬µÖµÖ®Ö Ûêú †®ŸÖÝÖÔŸÖ ¸üÖêÝÖ ÛúÖê ¯Ö×¸ü³ÖÖ×ÂÖŸÖ Ûú¸ü®ÖÖ

(iv) ×•ÖÃÖÛúÖ †¬µÖµÖ®Ö ×ÛúµÖÖ •ÖÖ®ÖÖ Æîü ˆÃÖ •Ö®ÖÃÖÓÜµÖÖ ÛúÖê ¯Ö×¸ü³ÖÖ×ÂÖŸÖ Ûú ü®ÖÖ

(D) (i) ×•ÖÃÖÛúÖ †¬µÖµÖ®Ö ×ÛúµÖÖ •ÖÖ®ÖÖ Æîü ˆÃÖ •Ö®ÖÃÖÓÜµÖÖ ÛúÖê ¯Ö×¸ü³ÖÖ×ÂÖŸÖ Ûú ü®ÖÖ

(ii) †¬µÖµÖ®Ö Ûêú †®ŸÖÝÖÔŸÖ ¸üÖêÝÖ ÛúÖê ¯Ö×¸ü³ÖÖ×ÂÖŸÖ Ûú¸ü®ÖÖ

(iii) ¸üÖêÝÖ ÛúÖ ´ÖÖ¯Ö®Ö

(iv) ÃÖ´ÖµÖ, Ã£ÖÖ®Ö ¾Ö ¾µÖ×ŒŸÖ Ûêú †®ÖãÃÖÖ¸ü ¸üÖêÝÖ ÛúÖ ¾ÖÞÖÔ®Ö Ûú¸ü®ÖÖ

38. ‹ÃÖ ‹ †Ö¸ü ‹ÃÖ Ûêú ¸üÖêÝÖ »ÖõÖÞÖÖë ÛúÖê ²ÖÖ¸ü´²ÖÖ¸üŸÖÖ Ûêú †Ö¬ÖÖ¸ü ¯Ö¸ü †¾Ö¸üÖêÆüß ÛÎú´Ö ´Öë ¾µÖ¾Ö×Ã£ÖŸÖ Ûú¸ëü :

(A) •¾Ö¸ü > 38° ÃÖß, ÜÖ¸üÖ²Ö ÝÖ»ÖÖ, •Öæ›Ìüß, ×ÃÖ¸ü¤ü¤Ôü

(B) •¾Ö¸ü > 38° ÃÖß, ×ÃÖ¸ü¤ü¤Ôü, •Öæ›Ìüß, ÜÖ¸üÖ²Ö ÝÖ»ÖÖ

(C) •¾Ö¸ü > 38° ÃÖß, ÜÖ¸üÖ²Ö ÝÖ»ÖÖ, ×ÃÖ¸ü¤ü¤Ôü, •Öæ›Ìüß

(D) •¾Ö¸ü > 38° ÃÖß, •Öæ›Ìüß, ×ÃÖ¸ü¤ü¤Ôü, ÜÖ¸üÖ²Ö ÝÖ»ÖÖ

39. ‹“Ö †Ö‡Ô ¾Öß Ûêú ÃÖÓÛÎú´ÖÞÖ ×®Ö´®Ö×»Ö×ÜÖŸÖ ºþ¯ÖÖë/´ÖÖÝÖÖí ÛúÖê †¾Ö üÖêÆüß ÛÎú´Ö ´Öë (ÃÖ²ÖÃÖê ‰ú¯Ö ü ÃÖê ®Öß“Öê Ûúß †Öê ü) ¾µÖ¾Ö×Ã£ÖŸÖ Ûú ëü :

(A) ¸üŒŸÖ †Ö¬ÖÖ®Ö, µÖÖî®Ö ÃÖÓÃÖÝÖÔ, ¯ÖÏÃÖ¾Ö¯Öæ¾ÖÔ, ¿»ÖêÂ´Ö»Ö ×—Ö»»Öß

(B) ¸üŒŸÖ †Ö¬ÖÖ®Ö, ¯ÖÏÃÖ¾Ö¯Öæ¾ÖÔ, µÖÖî®Ö ÃÖÓÃÖÝÖÔ, ¿»ÖêÂ´Ö»Ö ×—Ö»»Öß

(C) ¿»ÖêÂ´Ö»Ö ×—Ö»»Öß, ¯ÖÏÃÖ¾Ö¯Öæ¾ÖÔ, µÖÖî®Ö ÃÖÓÃÖÝÖÔ, ¸üŒŸÖ †Ö¬ÖÖ®Ö

(D) ¸üŒŸÖ †Ö¬ÖÖ®Ö, ¿»ÖêÂ´Ö»Ö ×—Ö»»Öß, ¯ÖÏÃÖ¾Ö¯Öæ¾ÖÔ, µÖÖî®Ö ÃÖÓÃÖÝÖÔ

Paper-II 16 D-81-14

40. Identify the correct sequence for the levels of prevention :

(A) (i) Primary prevention

(ii) Primordial prevention

(iii) Secondary prevention

(iv) Tertiary prevention

(B) (i) Primordial prevention

(ii) Secondary prevention

(iii) Primary prevention


(C) (i) Primordial prevention

(ii) Primary prevention

(iii) Secondary prevention


(D) (i) Primary prevention

(ii) Secondary prevention

(iii) Tertiary prevention

(iv) Primordial Prevention

Questions 41 to 50 are matching items. This consist of two lists of statements, terms or symbols

and candidate has to match an item in List – I with an item in List – II :

41. List – I

(Group)

List – II

(Daily Intake of Vitamin A

Recommended by ICMR)

(2010) a. Children (1 – 6 yrs) i. 600 Retinol (mcg)

b. Adolescents ii. 400 Retinol (mcg)

c. Pregnant women iii. 950 Retinol (mcg)

d. Lactating mother iv. 800 Retinol (mcg)

Codes :

a b c d

(A) i iii ii iv

(B) ii i iv iii

(C) iii iv ii i

(D) ii iii i iv

42. List – I

(Type of infection)

List – II

(Disease) a. Respiratory infection i. Viral hepatitis

b. Intestinal infection ii. Lymphatic filariasis

c. Surface infection iii. SARS

d. Arthropod-borne

infection

iv. Trachoma

Codes : a b c d (A) i iv iii ii (B) iii i iv ii (C) ii i iii iv (D) iv iii ii i

D-81-14 17 Paper-II

40. ¸üÖêÛú£ÖÖ´Ö Ûêú ÃŸÖ¸ü Ûêú †®ÖãÃÖÖ¸ü ÃÖÆüß ÛÎú´Ö Ûúß ¯ÖÆü“ÖÖ®Ö Ûú¸ëü …

(A) (i) ¯ÖÏÖ£Ö×´ÖÛú ¸üÖêÛú£ÖÖ´Ö (ii) †Ö×¤üÛúÖ»Öß®Ö ¸üÖêÛú£ÖÖ´Ö (iii) ´ÖÖ¬µÖ×´ÖÛú ¸üÖêÛú£ÖÖ´Ö (iv) ŸÖéŸÖßµÖ ¸üÖêÛú£ÖÖ´Ö (B) (i) †Ö×¤üÛúÖ»Öß®Ö ¸üÖêÛú£ÖÖ´Ö (ii) ´ÖÖ¬µÖ×´ÖÛú ¸üÖêÛú£ÖÖ´Ö (iii) ¯ÖÏÖ£Ö×´ÖÛú ¸üÖêÛú£ÖÖ´Ö (iv) ŸÖéŸÖßµÖ ¸üÖêÛú£ÖÖ´Ö (C) (i) †Ö×¤üÛúÖ»Öß®Ö ¸üÖêÛú£ÖÖ´Ö (ii) ¯ÖÏÖ£Ö×´ÖÛú ¸üÖêÛú£ÖÖ´Ö (iii) ´ÖÖ¬µÖ×´ÖÛú ¸üÖêÛú£ÖÖ´Ö (iv) ŸÖéŸÖßµÖ ¸üÖêÛú£ÖÖ´Ö (D) (i) ¯ÖÏÖ£Ö×´ÖÛú ¸üÖêÛú£ÖÖ´Ö (ii) ´ÖÖ¬µÖ×´ÖÛú ¸üÖêÛú£ÖÖ´Ö (iii) ŸÖéŸÖßµÖ ¸üÖêÛú£ÖÖ´Ö (iv) †Ö×¤üÛúÖ»Öß®Ö ¸üÖêÛú£ÖÖ´Ö

¯ÖÏ¿®Ö 41 ÃÖê 50 ÃÖã´Öê»Ö®Ö ´Ö¤ü Æïü … ‡®Ö´Öë Ûú£Ö®ÖÖë, ¯Ö¤üÖë †£Ö¾ÖÖ ¯ÖÏŸÖßÛúÖë Ûúß ¤üÖê ÃÖæ×“ÖµÖÖÑ Æïü … †Ö¯ÖÛúÖê ÃÖæ“Öß-I Ûêú ´Ö¤üÖë ÛúÖê ÃÖæ“Öß-II Ûêú ´Ö¤üÖë ÃÖê ÃÖã´Öê×»ÖŸÖ Ûú¸ü®ÖÖ Æîü … 41. Ã Öæ “ Öß-I

(Ã Ö´ Öæ Æü ) Ã Öæ “ Öß-II

(20 10) †Ö‡Ô Ã Öß ‹´ Ö †Ö ¸ü «ü Ö¸ü Ö †® Öã ¿ ÖÓ ×Ã ÖŸ Ö ×¾Ö™üÖ ×´ Ö® Ö ‹ Û úÖ ÝÖÏ ÆüÞÖ a. ²ÖÖ»ÖÛú (1-6) ¾ÖÂÖÔ i. 600 ¸êü×™ü®ÖÖò»Ö (‹´Ö ÃÖß •Öß) b. ×Ûú¿ÖÖê¸ü ii. 400 ¸êü×™ü®ÖÖò»Ö (‹´Ö ÃÖß •Öß) c. ÝÖ³ÖÔ¾ÖŸÖß Ã¡Öß iii. 950 ¸êü×™ü®ÖÖò»Ö (‹´Ö ÃÖß •Öß) d. ÃŸÖ®Ö¯ÖÖ®Ö Ûú¸üÖ®Öê ¾ÖÖ»Öß ´ÖÖŸÖÖ‹Ñ iv. 800 ¸êü×™ü®ÖÖò»Ö (‹´Ö ÃÖß •Öß)

Û æ ú™ü : a b c d (A) i iii ii iv (B) ii i iv iii (C) iii iv ii i (D) ii iii i iv

42. ‡Ó±îúŒ¿Ö®Ö ÛúÖ ¯ÖÏÛúÖ¸ü †Öî¸ü ¸üÖêÝÖ : Ã Öæ “ Öß-I

(‡® ±î úŒ¿ Ö® Ö Û úÖ ¯ ÖÏ Û úÖ¸ü ) Ã Öæ “ Öß-II

(¸ü Öê ÝÖ) a. ¿¾ÖÖÃÖ ÃÖÓ²ÖÓ¬Öß ‡®±îúŒ¿Ö®Ö i. ¾ÖÖµÖ¸ü»Ö ×Æü¯Öî™üÖ‡×™üÃÖ b. †ÖÓ¡Ö ÃÖÓ²ÖÓ¬Öß ‡®±îúŒ¿Ö®Ö ii. ×»Ö´±îú×™üÛú ±úÖ‡»Öê×¸ü‹×ÃÖÃÖ c. ÃÖ±ìúÃÖ ‡®±îúŒ¿Ö®Ö iii. ÃÖÖÃÖÔ d. †Ö£ÖÐÖì¯ÖÖò›ü ²ÖÖê®ÖÔ ‡®±îúŒ¿Ö®Ö iv. ™ÒîüÛúÖê´ÖÖ

Û æ ú™ü : a b c d (A) i iv iii ii (B) iii i iv ii (C) ii i iii iv (D) iv iii ii i

Paper-II 18 D-81-14

43. List – I

(Health Facility)

List – II

(Population Served)

a. Primary Health Centre i. 400 – 800

b. Anganwadi Centre ii. 150 – 300

c. Mini Anganwadi Centre iii. 1,00,000

d. Community Health Centre iv. 30,000

Codes :

a b c d

(A) i ii iv iii

(B) iv i ii iii

(C) ii iii i iv

(D) i iv iii ii

44. List – I

(National Health Program)

List – II

(Worker)

a. Revised National Tuberculosis

Control Programme

i. ICTC counsellor

b. ICDS ii. STLS

c. NRHM iii. Anganwari worker

d. National AIDS control programme iv. ASHA

Codes :

a b c d

(A) i iii ii iv

(B) iii ii iv i

(C) ii iii iv i

(D) iv iv i ii

45. List – I

(Level of Anaemia among

women aged 15 – 49 yrs;

data source : NFHS3)

List – II

(State)

a. 43.4 % i. Delhi

b. 53.3 % ii. Karnataka

c. 50.3 % iii. Himachal Pradesh

d. 40.9 % iv. Tamil Nadu

Codes :

a b c d

(A) i ii iii iv

(B) ii iv iii i

(C) i iv ii iii

(D) iii ii i iv

D-81-14 19 Paper-II

43. Ã Öæ “ Öß-I (Ã ¾ÖÖÃ £ µÖ ÝÖ×Ÿ Ö×¾Ö×¬Ö)

Ã Öæ “ Öß-II (Ã Öê ×¾ÖŸ Ö •Ö® ÖÃÖÓ ÜµÖÖ)

a. ¯ÖÏÖ£Ö×´ÖÛú ÃÖê¾ÖÖ Ûêú®¦ü i. 400-800

b. †ÖÓÝÖ®Ö²ÖÖ›Ìüß Ûêú®¦ü ii. 150-300

c. »Ö‘Öã †ÖÓÝÖ®Ö²ÖÖ›Ìüß Ûêú®¦ü iii. 1,00,000

d. ÃÖÖ´Öã¤üÖ×µÖÛú Ã¾ÖÖÃ£µÖ Ûêú®¦ü iv. 30,000

Û æ ú™ü : a b c d

(A) i ii iv iii

(B) iv i ii iii

(C) ii iii i iv

(D) i iv iii ii

44. Ã Öæ “ Öß-I (¸ü ÖÂ™Ò ü ßµÖ Ã ¾ÖÖÃ£ µÖ Û úÖµÖÔ ÛÎ ú´ Ö)

Ã Öæ “ Öß-II (Û úÖµÖÔ Û úŸ ÖÖÔ )

a. ÃÖÓ¿ÖÖê×¬ÖŸÖ ¸üÖÂ™ÒüßµÖ õÖµÖ ¸üÖêÝÖ ×®ÖµÖÓ¡ÖÞÖ ÛúÖµÖÔÛÎú´Ö

i. †Ö‡Ô ÃÖß ™üß ÃÖß ÃÖ»ÖÖÆüÛúÖ¸ü

b. †Ö‡Ô ÃÖß ›üß ‹ÃÖ ii. ‹ÃÖ ™üß ‹»Ö ‹ÃÖ c. ‹®Ö †Ö¸ü ‹“Ö ‹´Ö iii. †ÖÓÝÖ®Ö²ÖÖ›Ìüß ÛúÖµÖÔÛúŸÖÖÔ d. ®Öê¿Ö®Ö»Ö ‹›ËüÃÖ ×®ÖµÖÓ¡ÖÞÖ ÛúÖµÖÔÛÎú´Ö iv. †Ö¿ÖÖ


(A) i iii ii iv

(B) iii ii iv i

(C) ii iii iv i

(D) iv iv i ii

45. Ã Öæ “ Öß-I (15 -49 ¾ÖÂÖÔ Û úß ´ Ö×Æü »ÖÖ†Öë ´ Öë ¸üŒŸ Ö †»¯ ÖŸ ÖÖ Û úÖ

Ã Ÿ Ö¸ü †ÖÑ Û ú›Ì üÍ Ö ÄÖÖêŸ Ö : ‹® Ö ‹±ú ‹ “ Ö ‹Ã Ö 3)

Ã Öæ “ Öß-II (¸ü Ö•µÖ)

a. 43.4% i. ×¤ü»»Öß b. 53.3% ii. Ûú®ÖÖÔ™üÛú c. 50.3% iii. ×Æü´ÖÖ“Ö»Ö ¯ÖÏ¤êü¿Ö d. 40.9% iv. ŸÖ×´Ö»Ö®ÖÖ›ãü


(A) i ii iii iv

(B) ii iv iii i

(C) i iv ii iii

(D) iii ii i iv

Paper-II 20 D-81-14

46. List – I

(State)

List – II

(Level of stunting among

children aged < 3 years;

data source : NFHS 3)

a. Andhra Pradesh i. 38 %

b. Kerala ii. 25 %

c. Tamil Nadu iii. 34 %

d. Karnataka iv. 21 %

Codes :

a b c d

(A) iii i iv ii

(B) iii ii iv i

(C) iii i ii iv

(D) i iv ii iii

47. Vaccine and adverse event :

List – I

(Vaccine)

List – II

(Adverse Event)

a. OPV i. Lymphadenitis

b. MMR ii. Brachial neuritis

c. BCG iii. Acute flaccid paralysis

d. Tetanus iv. Arthralgia

Codes :

a b c d

(A) ii iii iv i

(B) iv i ii iii

(C) iii iv i ii

(D) i iv iii ii

48. List – I List – II

(IUD device) (Approved duration of use)

a. Cu-T-380A i. 5 years

b. Cu-T-200 ii. 1 year

c. Nova T iii. 10 years

d. Progesterone-releasing IUD iv. 4 years

Codes :

a b c d

(A) i iii iv ii

(B) ii iv i iii

(C) iii iv i ii

(D) iv ii iii i

D-81-14 21 Paper-II

46. Ã Öæ “ Öß-I (¸ü Ö•µÖ)

Ã Öæ “ Öß-II (3 Ã ÖÖ»Ö Û ê ú ²Ö“ “ ÖÖë ´ Öë ²ÖÖî® Öê Ö® Ö ÛúÖ Ã Ÿ Ö¸ü -

†ÖÑ Û ú› Ìü Í Ö ÄÖÖê Ÿ Ö – ‹® Ö ‹±ú ‹“ Ö ‹Ã Ö – 3) a. †ÖÓ¬ÖÐ ¯ÖÏ¤êü¿Ö i. 38%

b. Ûêú¸ü»Ö ii. 25%

c. ŸÖ×´Ö»Ö®ÖÖ›ãü iii. 34%

d. Ûú®ÖÖÔ™üÛú iv. 21%


(A) iii i iv ii

(B) iii ii iv i

(C) iii i ii iv

(D) i iv ii iii

47. ™üßÛúÖ †Öî ü ¯ÖÏ×ŸÖÛæú»Ö ×Ã£Ö×ŸÖ : Ã Öæ “ Öß-I

(™ü ßÛ úÖ) Ã Öæ “ Öß-II

(¯ ÖÏ ×Ÿ ÖÛ æ ú»Ö ×Ã £Ö×Ÿ Ö) a. †Öê ¯Öß ¾Öß i. ×»Ö´±êú›üß®ÖÖ‡×™üÃÖ b. ‹´Ö ‹´Ö †Ö¸ü ii. ²ÖÎê×ÛúµÖ»Ö ®µÖæ¸üÖ‡×™üÃÖ c. ²Öß ÃÖß •Öß iii. ‹ŒµÖæ™ü °»Öê×ÃÖ›ü ¯Öî¸üÖ»ÖÖµÖ×ÃÖÃÖ d. ×™ü™êü®ÖÃÖ iv. †£ÖÔ¸ü»Ö×•ÖµÖÖ


(A) ii iii iv i

(B) iv i ii iii

(C) iii iv i ii

(D) i iv iii ii

48. †Ö‡Ô µÖæ ›üß ×›ü¾ÖÖ‡ÃÖ ‹¯ÖÏæ¾›ü ›ü¶æ¸êü¿Ö®Ö †Öò±ú µÖæ•ÖÌ †Ö‡Ô µÖæ › ü ß ×› ü ¾ÖÖ‡Ã Ö ‹¯ ÖÏ æ ¾› ü › ü ¶æ ê ü¿ Ö® Ö †Öò ±ú µÖæ •Ö

a. Cu ™üß-380 ‹ i. 5 ÃÖÖ»Ö b. Cu ™üß-200 ii. 1 ÃÖÖ»Ö c. ®ÖÖê¾ÖÖ ™üß iii. 10 ÃÖÖ»Ö d. ¯ÖÏÖê•ÖêÃ™êü¸üÖê®Ö-×¸ü×»ÖØ•ÖÝÖ †Ö‡Ô µÖæ ›üß iv. 4 ÃÖÖ»Ö


(A) i iii iv ii

(B) ii iv i iii

(C) iii iv i ii

(D) iv ii iii i

Paper-II 22 D-81-14

49. List – I

(State)

List – II

(Level of wasting among

children aged < 3 years;

data source : NFHS 3)

a. Bihar i. 18

b. Chhattisgarh ii. 28

c. Jharkhand iii. 31

d. Madhya Pradesh iv. 33

Codes :

a b c d

(A) ii iii iv i

(B) ii i iii iv

(C) i iii iv ii

(D) i iv iii ii

50. List – I

(Fertility Indicator)

List – II

(Definition)

a. General Fertility Rate i. Average number of girls that would be born

to a woman if she experiences current

fertility patterns throughout her reproductive

span assuming no mortality.

b. Total fertility Rate ii. Number of live births per 1000 women in

the reproductive age group (15-44 or 49) in

a given year.

c. Gross Reproduction Rate iii. Number of daughters a newborn girl will

bear during her life time assuming fixed age

specific fertility and mortality rates.

d. Net Reproductive Rate iv. Average number of children a woman

would have if she were to pass through her

reproductive years bearing children at the

same rate as women in each age group.

Codes :

a b c d

(A) ii i iv iii

(B) iii ii i iv

(C) i iii iv ii

(D) ii iv i iii

D-81-14 23 Paper-II

49. Ã Öæ “ Öß-I

(¸ü Ö•µÖ)

Ã Öæ “ Öß-II

(Ã Öæ ÜÖÖ (¾Öê ØÃ ™ü ÝÖ) Û úÖ ÃŸ Ö¸ü 3 Ã ÖÖ»Ö Û ê ú ²Ö“ “ ÖÖë ´ Öë, †ÖÑ Û ú›Ì üÍ ê Û úÖ ÄÖÖê Ÿ Ö – ‹® Ö ‹±ú

‹“ Ö ‹Ã Ö – 3)

a. ×²ÖÆüÖ¸ü i. 18

b. ”û¢ÖßÃÖÝÖœÌü ii. 28

c. —ÖÖ¸üÜÖÓ›ü iii. 31

d. ´Ö¬µÖ ¯ÖÏ¤êü¿Ö iv. 33

Û æ ú™ü :

a b c d

(A) ii iii iv i

(B) ii i iii iv

(C) i iii iv ii

(D) i iv iii ii

50. Ã Öæ “ Öß-I

(ˆ¾ÖÔ ¸ü Ÿ ÖÖ Ã ÖÓ Û ê úŸ ÖÛ ú)

Ã Öæ “ Öß-II

(¯ Ö×¸ü ³ÖÖÂÖÖ)

a. ÃÖÖ´ÖÖ®µÖ ˆ¾ÖÔ¸üŸÖÖ ¤ü¸ü i. †ÖîÃÖŸÖ »Ö›Ìü×ÛúµÖÖë Ûúß ÃÖÓÜµÖÖ •ÖÖê ‹êÃÖß Ã¡Öß ÃÖê ˆŸ¯Ö®®Ö Æãü‡Ô Æïü ×•ÖÃÖ®Öê ¾ÖŸÖÔ´ÖÖ®Ö ˆ¾ÖÔ üŸÖÖ ®Ö´Öæ®Öê ÛúÖê †ÃÖ´ÖÖ®Ö ºþ¯Ö ´Öë †¯Ö®Öê ¯Öæ êü ¯ÖÏ•Ö®Ö®Ö ÛúÖ»Ö ´Öë †®Öã³Ö¾Ö ×ÛúµÖÖ ÆüÖê †Öî¸ü ÛúÖê‡Ô ´ÖéŸµÖã ³Öß ®ÖÆüà Æãü‡Ô ÆüÖê …

b. Ûãú»Ö ˆ¾ÖÔ¸üŸÖÖ ¤ü¸ü ii. ‹Ûú ×¤ü‹ ÝÖ‹ ¾ÖÂÖÔ ´Öë (15-44 µÖÖ 49) †ÖµÖã ¾ÖÝÖÔ Ûúß ‹Ûú Æü•ÖÖ¸ü ¯ÖÏ•Ö®Ö®ÖßµÖ ×Ã¡ÖµÖÖë «üÖ¸üÖ •Öß×¾ÖŸÖ •Ö®´Ö Ûúß ÃÖÓÜµÖÖ

c. Ûãú»Ö (ÝÖÏÖòÃÖ) ¯ÖÏ•Ö®Ö®Ö ¤ü¸ü

iii. ²Öê×™üµÖÖë Ûúß ÃÖÓÜµÖÖ ÛúÖê ‹Ûú ®Ö¾Ö•ÖÖŸÖ »Ö›ÌüÛúß †¯Ö®Öê •Öß¾Ö®ÖÛúÖ»Ö ´Öë ‹Ûú ×®Ö×¿“ÖŸÖ †ÖµÖã ´Öë ˆŸ¯Ö®®Ö Ûú¸êüÝÖß ¾Ö ×¾Ö¿ÖêÂÖ ˆŸ¯ÖÖ¤üÛúŸÖÖ ¾Ö ´ÖéŸµÖã ¤ü ü ŒµÖÖ ÆüÖêÝÖß …

d. Ûãú»Ö (®Öî™ü) ¯ÖÏ•Ö®Ö®Ö ¤ü¸ü

iv. ‹Ûú Ã¡Öß †ÖîÃÖŸÖ ²Ö““ÖÖë ÛúÖê •Ö®´Ö ¤êüÝÖß †ÝÖ¸ü ¾ÖÆü †¯Ö®Öê ¯ÖÏ•Ö®Ö®Ö ÛúÖ»Ö ÃÖê ÝÖã•Ö¸üŸÖß Æîü †Öî¸ü ¯ÖÏŸµÖêÛú †ÖµÖã ¾ÖÝÖÔ Ûúß †Öî¸üŸÖÖë Ûêú ÃÖ´ÖÖ®Ö Æüß ˆÃÖÛúß ¯ÖÏ•Ö®Ö®Ö õÖ´ÖŸÖÖ ÆüÖêÝÖß

Û æ ú™ü :

a b c d

(A) ii i iv iii

(B) iii ii i iv

(C) i iii iv ii

(D) ii iv i iii

___________

Space For Rough Work

Paper-II 24 D-81-14

paper-ii social medicine & community health · 2019. 9. 29. · paper-ii 2 d-81-14 social...

Documents